HET COLLEGE
VOOR DE TOELATING VAN
GEWASBESCHERMINGSMIDDELEN
EN BIOCIDEN
1
VERLENGING TOELATING
Gelet op de aanvraag d.d. 23 augustus 2007 (20071060 TVB) van
tot verlenging van de toelating voor de biocide, op basis van de werkzame stof natriumdichloorisocyanuraat
gelet op artikel 122, Wet gewasbeschermingsmiddelen en biociden,
BESLUIT HET COLLEGE als volgt:
1.1 Verlenging toelating
1. De toelating van het middel P3-ansep chloortabletten, welke expireert op 1 november 2010 wordt voor de in bijlage I genoemde toepassingen verlengd onder nummer 6377. Voor de gronden van dit besluit wordt verwezen naar bijlage II bij dit besluit.
2. De toelating geldt tot het tijdstip waarop de lidstaten maatregelen genomen hebben om de nationale toelating in overeenstemming te brengen met het besluit over de werkzame stof van de Europese Commissie.
1.2 Samenstelling, vorm en verpakking
De toelating geldt uitsluitend voor het middel in de samenstelling, vorm en de verpakking als waarvoor de toelating is verleend.
1.3 Gebruik
Het middel mag slechts worden gebruikt met inachtneming van hetgeen in bijlage I onder A bij dit besluit is voorgeschreven.
1.4 Classificatie en etikettering
Gelet op artikel 50, eerste lid, sub d, Wet gewasbeschermingsmiddelen en
biociden,
1. De aanduidingen, welke ingevolge artikelen 9.2.3.1 en 9.2.3.2 van de Wet milieubeheer en artikelen 14, 15a, 15b, 15c en 15d van de Nadere regels verpakking en aanduiding milieugevaarlijke stoffen en preparaten op de verpakking moeten worden vermeld, worden hierbij vastgesteld als volgt:
aard van het preparaat: Tablet
werkzame stof: |
gehalte: |
natriumdichloorisocyanuraat |
86 % |
letterlijk en zonder enige
aanvulling:
andere zeer giftige, giftige, bijtende of schadelijke stof(fen):
gevaarsymbool: |
aanduiding: |
Xn |
Schadelijk |
O |
Oxiderend |
N |
Milieugevaarlijk |
Waarschuwingszinnen:
R08 -Bevordert
de ontbranding van brandbare stoffen.
R22 -Schadelijk
bij opname door de mond.
R31 -Vormt
vergiftige gassen in contact met zuren.
R36/37 -Irriterend
voor de ogen en de ademhalingswegen.
R50/53 -Zeer
vergiftig voor in het water levende organismen; kan in het aquatisch milieu op
lange termijn schadelijke effecten veroorzaken.
Veiligheidsaanbevelingen:
S08 -Verpakking
droog houden.
S21 -Niet
roken tijdens gebruik.
S26 -Bij
aanraking met de ogen onmiddellijk met overvloedig water afspoelen en deskundig
medisch advies inwinnen.
S36/37/39b -Draag
geschikte beschermende kleding, handschoenen en een beschermingsmiddel voor het
gezicht.
S60 -Deze
stof en de verpakking als gevaarlijk afval afvoeren. (Deze zin hoeft niet te
worden vermeld op het etiket indien u deelneemt aan het verpakkingenconvenant,
en op het etiket het STORL-vignet voert, en ingevolge dit convenant de
toepasselijke zin uit de volgende verwijderingszinnen op het etiket vermeldt:
Deze verpakking is bedrijfsafval, mits deze is schoongespoeld, zoals
wettelijk is voorgeschreven.
Deze verpakking is bedrijfsafval, nadat deze volledig is geleegd.
Deze verpakking dient nadat deze volledig is geleegd te worden
ingeleverd bij een KCA-depot. Informeer bij uw gemeente.)
S61 -Voorkom
lozing in het milieu. Vraag om speciale instructies / veiligheidsgegevenskaart.
Specifieke vermeldingen:
-
1)
Behalve de onder 1. bedoelde en de overige bij
de Wet Milieugevaarlijke Stoffen en Nadere regels verpakking en aanduiding
milieugevaarlijke stoffen en preparaten voorgeschreven aanduidingen en
vermeldingen moeten op de verpakking voorkomen:
§
letterlijk en zonder enige aanvulling:
het wettelijk gebruiksvoorschrift
De tekst van het wettelijk gebruiksvoorschrift is opgenomen in Bijlage I, onder
A.
§
hetzij
letterlijk, hetzij naar zakelijke inhoud:
de gebruiksaanwijzing
De tekst van de gebruiksaanwijzing
is opgenomen in Bijlage I, onder B.
De tekst mag worden aangevuld met technische aanwijzingen voor een goede
bestrijding mits deze niet met die tekst in strijd zijn.
2 DETAILS VAN DE AANVRAAG
EN TOELATING
2.1 Aanvraag
De toelating van het middel P3-ansep chloortabletten is laatstelijk bij besluit d.d. 13 oktober 2000 verlengd tot 1 november 2010. Het betreft een
aanvraag tot verlenging van de toelating van het middel P3-ansep chloortabletten (6377 N), een middel op basis van de werkzame stof natriumdichloorisocyanuraat. De verlenging wordt aangevraagd voor de
toelating als middel ter bestrijding van bacteriën (excl.
mycobacteriën en bacteriesporen), klassieke varkenspest virus, virus van de
ziekte van Aujeszky en mond- en klauwzeer virus:
-
op plaatsen, waar eet- en
drinkwaren worden bereid, behandeld of bewaard;
-
in ruimten, bestemd voor
verblijf van mensen, echter met uitzondering van ziekenhuizen en overige
instellingen voor gezondheidszorg;
-
in dierverblijfplaatsen
en bijbehorende ruimten;
-
in transportmiddelen voor
dieren.
2.2 Informatie met betrekking tot de stof
-
2.3 Karakterisering van het middel
-
2.4 Voorgeschiedenis
De aanvraag is op 23 augustus 2007 ontvangen; op 27 september 2007 en 30 juli 2010 zijn de verschuldigde aanvraag- en beoordelingskosten ontvangen.
2.5 Eindconclusie
Bij gebruik volgens het Wettelijk
Gebruiksvoorschrift/Gebruiksaanwijzing is het middel
P3-ansep chloortabletten op basis van de werkzame stof natriumdichloorisocyanuraat voldoende werkzaam en heeft het geen schadelijke
uitwerking op de gezondheid van de mens en het milieu (artikel 28, Wet
gewasbeschermingsmiddelen en biociden).
HET COLLEGE VOOR
DE TOELATING VAN
GEWASBESCHERMINGSMIDDELEN EN
BIOCIDEN,
dr. D. K. J. Tommel
voorzitter
HET COLLEGE VOOR DE
TOELATING VAN GEWASBESCHERMINGSMIDDELEN EN BIOCIDEN
BIJLAGE I bij het besluit d.d. 29 oktober 2010 tot verlenging van de toelating van het middel P3-ansep chloortabletten, toelatingnummer 6377 N
A.
WETTELIJK
GEBRUIKSVOORSCHRIFT
Toegestaan is uitsluitend het gebruik als
middel ter bestrijding van bacteriën (excl. mycobacteriën en bacteriesporen),
klassieke varkenspest virus, virus van de ziekte van Aujeszky en mond- en
klauwzeer virus:
-
op plaatsen, waar eet- en
drinkwaren worden bereid, behandeld of bewaard;
-
in ruimten, bestemd voor
verblijf van mensen, echter met uitzondering van ziekenhuizen en overige
instellingen voor gezondheidszorg;
-
in dierverblijfplaatsen
en bijbehorende ruimten;
-
in transportmiddelen voor
dieren.
Het middel is uitsluitend bestemd voor
professioneel gebruik.
B.
GEBRUIKSAANWIJZING
De te desinfecteren oppervlakken en materialen
eerst grondig reinigen. Een daarbij eventueel gebruikt reinigingsmiddel vervolgens
afspoelen met schoon water. Overtollige vloeistof verwijderen.
De minimale inwerkingstijd is 5 minuten.
Onder laboratoriumomstandigheden is het middel
in een concentratie van 10 tabletten per
10 liter water en bij een Minimale inwerkingstijd van 5 minuten werkzaam
gebleken tegen klassieke varkenspest virus, tegen het virus van de ziekte van
Aujeszky en tegen mond- en klauwzeer virus.
Bij het desinfecteren zoveel vloeistof
gebruiken, dat de oppervlakken gedurende de inwerkingsduur nat blijven.
Desinfectie van melkmachines, melkleidingsystemen,
melkkoeltanks en materialen op de boerderij.
Dosering: 1 tablet per
Desinfectie van oppervlakken en materialen,
die direct met levensmiddelen in aanraking komen in de gehele voedings- en
genotmiddelenindustrie.
Algemene desinfectie van vloeren, tafels,
materialen, sanitair (o.a. toiletten, closetpotten, spoelbakken) enz.
Dosering: 1 tablet op
Dierverblijfplaatsen en bijbehorende ruimten.
Dosering: 5 tabletten per
Transportmiddelen voor dieren
De ontsmetting is vooral gericht op de
bestrijding van een aantal besmettelijke veeziekten, zoals bedoeld in de Veewet.
Voor de ontsmetting moet grondig worden gereinigd. De ontsmettingsoplossing
wordt gemaakt door 10 tabletten per
Deze oplossing over de gereinigde oppervlakken (vloeren en wanden) verspreiden
en minimaal 5 minuten laten inwerken.
Oppervlakken die met voedingsmiddelen in
aanraking komen, naspoelen met schoon water.
Waarschuwingen:
- Verneveling van het middel is niet toegestaan.
- Het middel niet in direct contact met dieren laten komen.
- Toepassing alleen met gebruik van beschermde kleding (overall), gezichtsbescherming en handschoenen.
- Ter voorkoming van nadelige effecten voor bodemorganismen dient de desinfectie van dier transportmiddelen te worden uitgevoerd op locaties met een verharde ondergrond met afvoer naar een riool met aansluiting op de RWZI.
HET COLLEGE VOOR DE
TOELATING VAN GEWASBESCHERMINGSMIDDELEN EN BIOCIDEN
BIJLAGE II
bij het besluit d.d. 29 oktober 2010 tot verlenging
van de toelating van het middel P3-ansep
chloortabletten, toelatingnummer 6377 N
RISKMANAGEMENT
Contents
H.1 Introduction 4
H.2 Identity 5
H.3 Physical
and chemical properties 5
H.4 Analytical
methods for detection and identification 5
H.5 Efficacy 5
H.6 Human
toxicology 5
H.7 Environment 21
H.8 Conclusion 32
H.9 Classification
and labelling 33
H.10 References 36
Appendix 1 List of Endpoints sodiumdichloroisocyanurate and trichloroisocyanurate 37
Appendix 2 PNEC derivation 44
Appendix 3 Calculation sheets Environment 47
This assessments concerns prolongations of authorisations of Biocidal
products based on the active substances sodium dichloroisocyanurate and trichlorocyanuric acid.
The use of these products is disinfection
(PT2, PT3 and PT4). In table H.1 an overview of the uses is available.
Table
H.1 Overview of intended use
No. |
Product |
Area
of use envisaged |
Dosage
a.s.* |
|
|
PT2 |
|
1. |
Disochlorine
Chloortabletten Melquick P3-ansep Chloortabletten Suma Tab D4 |
Accommodations for
people |
|
2. |
Melquick Stafilex Chloortabletten Suma Tab D4 |
Areas/surfaces in
hospitals and health care facilities including medical instruments, cleaning
equipment, toilets, textiles etc. |
|
3. |
Actisan 5L Melpool 55/G Melpool 63/G Melquick Melpool 90 Tabletten** |
Therapeutic baths,
private pools (not part of hotels), camping sites, recreation centres or
boarding schools |
|
4. |
Actisan 5L |
Water in casks,
buckets, vases for flowers |
|
|
|
PT3 |
|
5. |
Melquick P3-Desinfekto P3-ansep Chloortabletten Stafilex Chloortabletten Suma Tab D4 |
Accommodations for
animals and annexes including cleaning equipment |
|
6. |
Actisan 5L P3-Desinfekto P3-ansep Chloortabletten Stafilex Chloortabletten Suma Tab D4 |
Vehicles for animal transport |
|
|
|
PT4 |
|
7. |
Actisan 5L Alfa plus P3-ansep Chloortabletten Stafilex Combi |
Milking equipment on
farms, including pipelines, tanks, machinery etc. |
|
8. |
Actisan 5L Disochlorine Chloortabletten Melquick P3-Desinfekto P3-ansep Chloortabletten Stafilex Chloortabletten Stafilex Combi Suma Tab D4 |
Locations where food
and drinks are prepared or stored – surfaces, instruments, systems, cleaning
equipment with or without direct food
contact. |
|
* Highest dosage selected from the different
uses of the products evaluated for prolongation.
** Product contains Trichloroisocyanuric acid
as active substance
n/a
n/a
n/a
n/a
Human health effects
assessment active substance
Sodium dichloroisocyanurate (NaDCC or troclosene sodium) is an existing active substance, not included in Annex
I of 98/8/EG. An application for inclusion is submitted, for which the
Trichlorocyanuric acid (TCCA or symclosene) is an existing active substance, not included in Annex I of 98/8/EG. An
application for inclusion is submitted, for which the
For both active substances,
a draft concept CA-report does not exist. Therefore, this assessment is based
on the physical chemical and toxicological data as provided in a report on
sodium dichloro-s-triazinetrione for the High Production Volume Chemical
Challenge Program (sodium dichloro-s-triazinetrione is troclosene sodium, May
2004), published by the US Environmental
Protection Agency (US EPA), and a
report on tichloro-s-triazinetrione for the High Production Volume Chemical
Challenge Program (tichloro-s-triazinetrione is symclosene, May 2004),
published by the US Environmental
Protection Agency (US EPA) and information from the Ctgb.
As both NaDCC and TCCA are
chlorinated isocyanurates, and most endpoints are based on read-across studies
performed with cyanuric acid, hypochlorite and chlorine, the list of endpoints
for both active substances is combined (indicating which substance was used for
the study).
Absorption, distribution, metabolism and excretion
in mammals (Annex IIA, point 6.2) |
|
Rate and extent of oral
absorption: |
CYA (cyanuric acid) 100% |
Rate and extent of dermal
absorption: |
According for physical
chemical properties CYA a default value of 100% should be used. However, as
is known from rat studies in which CYA
was applied dermally and poorly absorbed, a default value of 10% will be used for risk assessment
purposes. There are no data to
indicate the degree of dermal absorption of hypochlorite ions. However, the
potential of hypochlorite solutions
to penetrate the skin is low given its reactivity to proteinaceous material.
The absorption has therefore been assessed by assuming a default fraction of 10% that is penetrating the skin.
This is considered to be a worst-case assumption based on the indicated low
potential for dermal penetration. |
Distribution: |
Excretion of CYA was
mainly urinary. |
Potential for accumulation: |
No |
Rate and extent of
excretion: |
Excretion of CYA was
mainly urinary (> 95% at 5 mg/kg bw) with the remainder being faecal. For
oral dosing at 500 mg/kg bw, the proportion of faecal to urinary excretion is
variable at 14 – 73% urinary. In studies in humans receiving doses by the
oral route, analysis showed that 100% of the ingested CYA was excreted
without metabolism by the oral route within 24 hours of ingestion. |
Toxicologically significant metabolite |
None, chlorinated
isocyanurate reduced to chloride ions and cyanuric acid. |
Acute toxicity (Annex IIA, point 6.1) |
|
Rat LD50 oral |
NaDCC dihydrate: LD50 = 2094
mg/kg bw (male) LD50 = 1671
mg/kg bw (female) TCCA: LD50 = 787
mg/kg bw (male) LD50 = 868
mg/kg bw (female) CYA > 5000 mg/kg bw |
Rat LD50 dermal |
NaDCC dihydrate: LD50
> 5000 mg/kg TCCA: LD50 > 2000 mg/kg bw CYA > 5000 mg/kg bw |
Rat LC50 inhalation |
NaDCC dihydrate: LC50
> 0.27 mg/L and < 1.17 mg/L when measured gravimetrically TCCA: LC50
< 0.29 mg/L but > 0.09 mg/L when measured gravimetrically |
Skin irritation |
Corrosive |
Eye irritation |
Highly irritating |
Skin sensitization (test
method used and result) |
Not sensitising (0/10
sensitisation rate) Guinea-pig maximisation study. |
Repeated dose toxicity (Annex IIA, point 6.3) |
|
Species/ target / critical effect |
Performed on monosodium cyanurate Rat, male/ heart and urinary
tract/lesions in early parts of 2-year study Performed on sodium hypochlorite Rat, decrease body weight
and in specific organ weights, associated with some biochemical changes |
Lowest relevant oral
NOAEL / LOAEL |
Monosodium cyanurate NOAEL 2-year combined
toxicity/carcinogenicity study = 371 mg/kg bw/day (males only) Sodium hypochlorite NOAEL 90-day toxicity
study (2 independent studies) = 46.6 mg/kg bw/day (males only) |
Lowest relevant dermal
NOAEL / LOAEL |
NOAEC 0.1% hypochlorite solution |
Lowest relevant
inhalation NOAEL / LOAEL |
NOAEC 0.5 ppm (1 mg/m3)
chlorine gas (monkey and human volunteer study) |
Genotoxicity (Annex IIA,
point 6.6) |
There is no evidence of
genotoxicity of CYA in vitro or in vivo. |
Carcinogenicity (Annex IIA,
point 6.4) |
|
Species/type of tumour |
No evidence of carcinogenicity in 2-year combined
oral toxicity and carcinogenicity studies in the rat and mouse with
monosodium cyanurate or in 24-month-whole year studies in rat with chlorine. |
lowest dose with tumours |
Not applicable |
Reproductive toxicity (Annex IIA, point 6.8) |
|
Species/ Reproduction
target / critical effect |
Monosodium cyanurate rat development/no effect on reproductive targets noted. Maternal
toxicity only in teratogenicity study. Studies with chlorine did not show any teratogenic
or reproductive effects. |
Lowest relevant
reproductive NOAEL / LOAEL |
NOAEL maternal tox >500 mg/kg NOAEL teratogen >5000 mg/kg |
Species/Developmental
target / critical effect |
Performed on cyanuric
acid Rat/reproduction/no
effect on reproductive targets noted. |
Lowest relevant
developmental NOAEL / LOAEL |
NOAEL = 5375 ppm (470 –
500 mg/kg bw/day males only) offspring NOAEL adult toxicity (F2
generation) = 190 mg/kg bw/day, males only |
Neurotoxicity / Delayed neurotoxicity (Annex IIIA, point VI.1) |
|
Species/ target/critical effect |
No neurotoxicological
effects observed in repeat dose studies. (for both cyanuric acid and chlorine
studies) |
Lowest relevant
developmental NOAEL / LOAEL. |
|
Other toxicological studies (Annex IIIA, VI/XI) |
|
|
n/a |
Medical data (Annex IIA, point 6.9) |
|
|
n/a |
Summary (Annex IIA,
point 6.10) |
Value |
Study |
Safety factor |
ADI (if residues in food
or feed) |
CYA = 3.71 mg/kg/day |
2-year combined oral
toxicity/carcinogenicity |
100 |
|
Chlorine = 14.4 mg/kg
bw/day |
US EPA IRIS |
Not applicable |
AEL (Operator/Worker Exposure) |
CYA = 3.71 mg/kg/day |
2-year combined oral
toxicity/carcinogenicity |
100 |
|
Sodium hypochlorite =
0.47 mg/kg bw/day |
90-days combined oral
toxicity |
100 |
Drinking water limit |
Chlorine = 25.0 µg/l |
Dutch drinking water guidelines |
Not applicable |
ARfD (acute reference dose) |
CYA = 2.0 mg/kg |
Rabbit teratology study |
100 |
Data requirements active substance
No additional data
requirements are identified.
6.1
Human exposure assessment active substance
6.1.1
Identification of main paths of human exposure towards
active substance from its use in biocidal product
Actisan-5L
An application has been submitted for the extension of the authorisation of the biocidal
product Actisan-5L (8960N). Actisan-5L are tablets used as a: private and
public health area disinfectant (PT02), for surfaces, equipment, in swimming
pools, and in casks/buckets/vases for flowers, veterinary hygiene biocidal
product (PT03) and as a food and feed area disinfectant (PT04), containing 85%
sodium dichloroisocyanurate
as active substance.
The formulation Actisan-5L
is for professional use
ALFA PLUS
An application has been submitted for the extension of the authorisation
of the biocidal product ALFA PLUS (11482N). ALFA PLUS is a water soluble powder used as a
food and feed area disinfectant (PT04), containing 9.2% sodium dichloroisocyanurate as
active substance.
The formulation ALFA PLUS
is for professional use.
DISOCHLORINE CHLOORTABLETTEN
An application has been submitted for the extension of the authorisation
of the biocidal product DISOCHLORINE
CHLOORTABLETTEN (11292N). DISOCHLORINE
CHLOORTABLETTEN are tablets used as a: private and public health area
disinfectant (PT02), and food and feed area disinfectant (PT04), containing 85%
sodium dichloroisocyanurate
as active substance.
The formulation
DISOCHLORINE CHLOORTABLETTEN is for professional use.
MELPOOL 55/G
An application has been submitted for the extension of the authorisation
of the biocidal product MELPOOL 55/G (10038N). MELPOOL 55/G are granules used in therapeutic
baths or swimming pools for the control of micro-organisms in swimming water
(PT02) and contains sodium dichloroisocyanurate
(55% active chlorine) as active substance.
The formulation MELPOOL
55/G is for both professional and non-professional use.
MELPOOL 63/G
An application has been submitted for the extension of the authorisation
of the biocidal product MELPOOL 63/G (8081N). MELPOOL 63/G are granules used in therapeutic
baths or swimming pools for the control of micro-organisms in swimming water
(PT02) and contains 100% sodium dichloroisocyanurate as active substance.
The formulation MELPOOL
63/G is for both professional and non-professional use.
MELPOOL 90 TABLETTEN
An application has been submitted for the extension of the authorisation
of the biocidal product MELPOOL 90 TABLETTEN
(8151N). MELPOOL 90 TABLETTEN are
tablets used in therapeutic baths or swimming pools for the control of
micro-organisms in swimming water (PT02) and contains 100% trichlorocyanuric acid as
active substance.
The formulation MELPOOL 90
TABLETTEN is for both professional and
non-professional use.
Melquick
An application has been submitted for the extension of the authorisation
of the biocidal product Melquick (8813N). Melquick are tablets used as a: private and
public health area disinfectant (PT02), for surfaces, equipment and in swimming
pools, veterinary hygiene biocidal product (PT03) and as a food and feed area
disinfectant (PT04), and contains 53% sodium dichloroisocyanurate as active substance.
The formulation Melquick is
for both professional and non-professional use.
P3-ansep chloortabletten
An application has been submitted for the extension of the authorisation
of the biocidal product P3-ansep chloortabletten (6377N). P3-ansep chloortabletten are tablets used as
a: private and public health area
disinfectant (PT02), veterinary hygiene biocidal product (PT03) and feed area
disinfectant (PT04), containing 86% sodium dichloroisocyanurate as active substance.
The formulation P3-ansep
chloortabletten is for professional use.
P3-DESINFEKTO
An application has been submitted for the extension of the authorisation
of the biocidal product P3-DISINFEKTO (6571N). P3-DISINFEKTO are tablets used as a: veterinary hygiene biocidal product (PT03)
and feed area disinfectant (PT04), containing 41% sodium dichloroisocyanurate as
active substance.
The formulation
P3-DISINFEKTO is for professional use.
Stafilex Chloortabletten
An application has been submitted for the extension of the authorisation
of the biocidal product Stafilex Chloortabletten
(6706N). Stafilex Chloortabletten are
tablets used as a: private and public health area disinfectant (PT02), for both
surfaces as in swimming pools, veterinary hygiene biocidal product (PT03) and
as a food and feed area disinfectant (PT04), containing 85.5% sodium dichloroisocyanurate as
active substance.
The formulation Stafilex
Chloortabletten is for professional use.
Stafilex Combi
An application has been submitted for the extension of the authorisation
of the biocidal product Stafilex Combi
(5390N). Stafilex Combi is a powder used
as a food and feed area disinfectant (PT04), containing 3.4% sodium dichloroisocyanurate as
active substance.
The formulation Stafilex
Combi is for professional use.
Suma Tab D4
An application has been submitted for the extension of the authorisation
of the biocidal product Suma Tab D4 (7321N). Suma Tab D4 are tablets used as a: private
and public health area disinfectant (PT02), veterinary hygiene biocidal product
(PT03) and as a food and feed area disinfectant (PT04), containing 85% sodium dichloroisocyanurate as
active substance.
The formulation Suma Tab D4
is for professional use.
6.1.2
Professional exposure
The professional user can
be exposed to the products during:
6.1.3
Non-professional
exposure
The non-professional user
can be exposed to products containing sodium dichloroisocyanurate (MELPOOL
55/G, MELPOOL 63/G, and Melquick) or products containing trichlorocyanuric acid
(MELPOOL 90 TABLETTEN) during filling and maintenance of feeders of private
swimming pools.
6.1.4
Indirect exposure as a result of use of the active
substance in biocidal product
Disinfection of milking equipment or surfaces in kitchens
Actisan-5L, ALFA PLUS,
P3-ansep chloortabletten, P3-DESINFEKTO, and Stafilex Combi are used for the
disinfection of milking equipment. Furthermore, Actisan-5L, DISOCHLORINE
CHLOORTABLETTEN, Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex
Chloortabletten, Stafilex Combi, and Suma Tab D4 are used for the disinfection
of kitchens, in which food is treated or stored. Therefore, secondary exposure
of humans to cyanuric acid, HOCl and disinfection byproducts residues could
occur by eating foods from kitchens and/or drinking milk from milking equipment
that were treated with these products. However as it is indicated in the WG/GAs
that after the treatment milking equipment and/or kitchen surfaces should be
rinsed with clean (tap) water, therefore it is not expected that humans can be
indirectly exposed to cyanuric acid and chlorine by eating foods from kitchens
and/or drinking milk from milking equipment that were treated with these
products.
Disinfections of accommodations and annexes for animals and/or means of
transport for animals
Actisan-5L, Melquick,
P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex chloortabletten and Suma Tab
D4 are used for the disinfection of accommodations and annexes for animals.
Furthermore, Actisan-5L, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex
chloortabletten and Suma Tab D4 are also used for the disinfection of means of
transport for animals. This means that livestock can be exposed to cyanuric
acid, HOCl and disinfection byproducts and that humans can be exposed
indirectly by consumption of animal products containing cyanuric acid, HOCl and
disinfection byproducts residues. However as it is indicated in the WG/GAs that
all products should be kept out of reach from animals, therefore it is not
expected that humans can be indirectly exposed to cyanuric acid, HOCl and
disinfection byproducts residues by the use of these products in as a animal
hygiene product (PT3).
Swimming pool
Dermal, oral and inhalation
exposure of the general public to cyanuric acid, HOCl and disinfection
byproducts will occur during use of a swimming pool (swimming) treated with
Actisan-5L, MELPOOL 55/G, MELPOOL 63/G,
and MELPOOL 90 TABLETTEN.
6.2
Human health effects assessment product
6.2.1
Toxicity of the formulated product
The toxicity of the formulated product
does not change.
6.2.2
Data requirements formulated product
No additional data
requirements are identified.
6.3
Risk characterisation for human health
6.3.1
General aspects
AEL/AOELsystemic
The Plant Protection
Products and Biocides Regulations (NL: Rgb) prescribes the calculation of the
risk with an AEL based on allometric extrapolation in cases the existing
substance is not placed on Annex I. This method takes into account the caloric
demand of the species studied and results in a more specific value than the
EU-AEL for which in most cases a standard factor of 100 is applied.
Cyanuric acid
The calculation of the
systemic AEL for chronic is based on the lowest NOAEL of 371 mg/kg bw/day of two-year study studies with the rat.
Calculations from other studies result in higher AELs.
Safety factors are used to
compensate for the uncertainties, which arise, for example, from extrapolation
from the tested species to humans and the differences between experimental
circumstances, and to ensure that at the acceptable exposure level no adverse
health effects will occur.
Used factors are:
• extrapolation rat à human on basis of caloric demand 4
• other interspecies differences: 2.5
• intraspecies differences: (professional use) 10
• biological availability via oral route: 100%*
• weight of professional operator/worker:
* If the absorbed dose is
significantly lower (<80%) than the administered dose, this is adjusted by a
correction factor equal to the percentage absorption.
AELsystemic: 371 x 1 x 60 /
(4 x 2.5 x 10) = 222.6 mg cyanuric acid/day
Chlorine (based on read-across van NaOCl)
The calculation of the
systemic AEL for semi-chronic is based on the lowest NOAEL of 46.6 mg/kg
bw/day of two subchronic oral toxicity
studies with the rat. Calculations from other studies result in higher AELs.
Safety factors are used to
compensate for the uncertainties, which arise, for example, from extrapolation
from the tested species to humans and the differences between experimental
circumstances, and to ensure that at the acceptable exposure level no adverse
health effects will occur.
Used factors are:
• extrapolation rat à human on basis of caloric demand 4
• other interspecies differences: 2.5
• intraspecies differences: (professional use) 10
• extrapolation subchronic à chronic 2
• biological availability via oral route: 36.4%*
• weight of professional operator/worker:
* If the absorbed dose is
significantly lower (<80%) than the administered dose, this is adjusted by a
correction factor equal to the percentage absorption.
AELsystemic: 46.6 x 0.364 x
60 / (4 x 2.5 x 10 x 2) = 5 mg sodium hypochlorite/day
5 mg sodium
hypochlorite/person/day is identical to 0.08 mg sodium hypochlorite/kg bw/day.
The available chlorine from NaOCl is equivalent to multiplication of the amount
of NaOCl with MW (Cl2)/MW(NaOCl) = 71/74.4 = 0.95.
AELsystemic: 5 x 0.95 = 4.8
mg available chlorine/person/day
4.8 mg available
chlorine/person/day is identical to 0.08 mg available chlorine/kg bw/day.
Local effects and determination of local Acceptable Exposure Level (AELlocal)
Due to its
corrosive/irritating properties, sodium dichloroisocyanurate produces local
effects after a single exposure (skin and eye irritation) and repeated
exposure. Local toxic effects are caused by release of chlorinated species in
response to chlorine demand.
Sodium dichloroisocyanurate
produces free available chlorine, in the form of hyopchlorous acid (HOCl) as it dissolve in water. A series of
rapid equilibria occur involving hypochlorous acid, hypochlorite ion, six
chlorinated compounds and four non-chlorinated compounds. As the equilibria
involve all of the possible chlorinated isocyanurates, the toxicity of
trichloroisocyanuric acid (TCCA), sodium dichloroisocyanurate (NaDCC) and
sodium dichloroisocyanurate dihydrate (NaDCC.2H2O) will be virtually
equivalent at the same available chlorine concentration. As the free available
chlorine (in the form of HOCl) is hydrolysed by reaction with various
impurities in the water it is converted into chloride ion and additional free
available chlorine is released from the chlorinated isocyanurates in
solution. Once all of the available
chlorine has been reduced, the stable reaction products are cyanuric acid (CYA
or isocyanuric acid) or its salts (e.g. sodium isocyanurate or disodium
cyanurate) and chloride salts. Long-term systemic toxicity is due to the parent
species, CYA, which is formed upon degradation.
The NOAECs are based on a
read across to sodium hypochlorite.
Oral exposure
In the RAR of sodium
hypochlorite it was concluded that a 2-year drinking water study in rats
provided the overall NOAEC of 275 mg available chlorine/L drinking water,
equivalent to 409 mg HOCl/L. Applying an overall assessment factor of 10 for
inter- and intraspecies variability an oral
limit concentration (AEClocal oral) of 41 mg/L is derived.
Dermal exposure
Local effects were observed
in repeated dose dermal toxicity studies with NaOCl. On the basis of these
studies it was concluded that the NOAEL for repeated dermal exposure to sodium
hypochlorite solution was related to its cytotoxicity/irritating properties and
was dependent on the concentration of the applied solution. Therefore, skin
irritation was seen as a threshold for dermal toxicity. The dermal exposure
studies reflected the reversible irritant effects of sodium hypochlorite at the
doses tested.
In the RAR of sodium
hypochlorite it was concluded that a very conservative NOAEC for repeated
effects following dermal exposure to sodium hypochlorite solution is 0.1%,
equal to
Inhalation exposure
In the RAR for sodium
hypochlorite inhalation toxicity data on chlorine gas were used as a surrogate
assessment of the potential effects of sodium hypochlorite aerosol. In the RAR
it was concluded that the NOAEC for repeated exposure to chlorine gas in animal
(12 months monkey) as well as human volunteer (single exposure) studies was 0.5
ppm, equivalent to 1 mg/m3. This is more or less the same as the
Threshold Limit Value (TLV) for chlorine (Cl2) which is set at 1.5
mg/m3 (for 15 min, ceiling value; Dutch
Arbeidsomstandighedensbesluit). For this risk assessment an AELlocal
inhalation of 1.5 mg/m3 (15 min, ceiling value)
will be used.
Furthermore, household
bleach is freely available for domestic uses containing 5% sodium hypochlorite
6.3.2
Professional users
The professional user can
be exposed to the products during:
Oral exposure is deemed negligible as the user will not intently eat the
product. All products are either granules or in tablet form, therefore
inhalatory exposure is negligible and dermal exposure is the main route of
exposure. However, as contact time to the product is very short, the dermal
exposure is deemed negligible compared to the dermal exposure during
application or during use of the swimming pool.
The professional user can be inhalatory and dermally exposure during
course spraying to cyanuric acid: 5.5
g/L (worst case), 0.24 g/L, 0.69 g/L, 1.01 g/L, 1.38 g/L, 1.4 g/L, 1.38 g/L, 0.15 g/L and
1.38 g/L, for respectively Actisan-5L, ALFA PLUS, DISOCLORINE CHLOORTABLETTEN,
Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex Chloortabletten,
Stafilex Combi, and Suma Tab D4. Oral exposure is considered to be negligible
as the product is unlikely to reach the mouth directly.
The professional user can be inhalatory and dermally exposure during
course spraying to active chlorine: 6.0
g/L (worst case), 0.3 g/L, 0.75 g/L, 1.1 g/L, 1.5 g/L, 1.6 g/L, 1.5 g/L, 0.2 g/L and 1.5
g/L, for respectively Actisan-5L, ALFA PLUS, DISOCLORINE CHLOORTABLETTEN,
Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex Chloortabletten,
Stafilex Combi, and Suma Tab D4. Oral exposure is considered to be negligible
as the product is unlikely to reach the mouth directly.
Systemic effects
To calculate professional exposure to Actisan-5L (worst case for both
cyanuric acid and active chlorine), the User Guidance for the Technical notes
for Guidance on Human Exposure to Biocidal Products is applied. The following
points have been taken into consideration:
Cyanuric acid
Table T.1 Internal operator exposure to cyanuric acid
and risk assessment for the use of Actisan-5L
|
Route |
Estimated internal exposure a (mg /day) |
Systemic NL-AEL (mg/day) |
Risk-index b |
Manual downward/upward spraying on surfaces |
||||
Mixing/ Loading & Applicationc |
Respiratory |
0.72 |
222.6 |
<0.01 |
Dermal |
9.01 |
222.6 |
0.04 |
|
|
Total |
9.73 |
222.6 |
0.04 |
a Internal
exposure was calculated with:
·
biological availability via
the dermal route: 10% (default)
·
biological availability via
the respiratory route: 100% (worst
case)
b The risk-index is calculated by dividing the
internal exposure by the systemic AEL.
c External
exposure is estimated with Spraying Model 1 (TNsG).
d PPE: gloves
and coverall
When used according to the WG/GA, it can be concluded that no adverse
health effects are expected for the protected (gloves and coverall)
professional users to cyanuric acid as a result of the application of
Actisan-5L.
The same conclusion applies for ALFA PLUS, DISOCLORINE CHLOORTABLETTEN,
Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex Chloortabletten,
Stafilex Combi, and Suma Tab D4, as the diluted concentration of these products
is lower compared to Actisan-5L.
Active chlorine
Table T.2 Internal operator exposure to active
chlorine and risk assessment for the use of Actisan-5L
|
Route |
Estimated internal exposure a (mg /day) |
Systemic NL-AEL (mg/day) |
Risk-index b |
||
without PPE |
with PPE |
without PPE |
with PPE |
|||
Manual downward/upward spraying on surfaces |
||||||
Mixing/ Loading & applicationc |
Respiratory |
0.78 |
(0.78) |
4.8 |
0.16 |
(0.16) |
Dermal |
9.83 |
0.72 |
4.8 |
2.05 |
0.15 |
|
|
Total |
10.61 |
1.50 |
4.8 |
2.21 |
0.31d |
a Internal
exposure was calculated with:
·
biological availability via
the dermal route: 10% (default)
·
biological availability via
the respiratory route: 100% (worst
case)
b The risk-index is calculated by dividing the
internal exposure by the systemic AEL.
c External
exposure is estimated with Spraying Model 1 (TNsG).
d PPE: gloves
and coverall
When used according to the WG/GA, it can be concluded that no adverse
health effects are expected for the protected (gloves and coverall)
professional users to active chlorine as a result of the application of
Actisan-5L.
As adverse effects are expected
from the unprotected professional users of Actisan-5L, the second worst case is
calculated below; P3-DISINFEKTO with an maximum diluted concentration of 1.6
g/L.
Table T.3 Internal operator exposure to active
chlorine and risk assessment for the use of P3-DESINFEKTO
|
Route |
Estimated internal exposure a (mg /day) |
Systemic NL-AEL (mg/day) |
Risk-index b |
Manual downward/upward spraying on surfaces |
||||
Mixing/ Loading & Applicationc |
Respiratory |
0.21 |
4.8 |
0.04 |
Dermal |
2.62 |
4.8 |
0.55 |
|
|
Total |
2.83 |
4.8 |
0.59 |
a Internal
exposure was calculated with:
·
biological availability via
the dermal route: 10% (default)
·
biological availability via
the respiratory route: 100% (worst case)
b The risk-index is calculated by dividing the
internal exposure by the systemic AEL.
c External
exposure is estimated with Spraying Model 1 (TNsG).
d PPE: gloves
and coverall
When used according to the WG/GA, it can be concluded that no adverse
health effects are expected for the unprotected professional users to active
chlorine as a result of the application of P3-DESINFEKTO.
The same conclusion applies for ALFA PLUS, DISOCLORINE CHLOORTABLETTEN,
Melquick, P3-ansep chloortabletten, Stafilex chloortabletten, Stafilex Combi,
and Suma Tab D4, as the diluted concentration of these products is lower
compared to P3-DISINFEKTO.
Disinfection byproducts
As the sodium hypochlorite RAR describes that the amount of chlorinated
by-products discharged (measured as absorbable organic halogens) have been
shown to be typically in the order of 0.5% of the available chlorine applied.
6 g/L (Actisan-5L) x 0.5% = 0.03 g/L chlorine.
Table T.4 Internal operator exposure to disinfection
byproducts and risk assessment for the use of Actisan-5L
|
Route |
Estimated internal exposure a (mg /day) |
Systemic NL-AEL (mg/day) |
Risk-index b |
Manual downward/upward spraying on surfaces |
||||
Mixing/ Loading & Applicationc |
Respiratory |
<0.01 |
4.8 |
<0.01 |
Dermal |
0.05 |
4.8 |
0.01 |
|
|
Total |
0.05 |
4.8 |
0.01 |
a Internal
exposure was calculated with:
·
biological availability via
the dermal route: 10% (default)
·
biological availability via
the respiratory route: 100% (worst
case)
b The risk-index is calculated by dividing the
internal exposure by the systemic AEL.
c External
exposure is estimated with Spraying Model 1 (TNsG).
d PPE: gloves
and coverall
When used according to the WG/GA, it can be concluded that no adverse
health effects are expected for the unprotected professional users to
disinfection byproducts as a result of the application of Actisan-5L.
The same conclusion applies for ALFA PLUS, DISOCLORINE CHLOORTABLETTEN,
Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex Chloortabletten,
Stafilex Combi, and Suma Tab D4, as the diluted concentration of these products
is lower compared to Actisan-5L.
Local effects
Dermal and upper respiratory tract exposure to active chlorine: 6.0 g/L (worst case), 0.3 g/L, 0.75
g/L, 1.1 g/L, 1.5 g/L, 1.6 g/L, 1.5 g/L,
0.2 g/L and 1.5 g/L, for respectively Actisan-5L, ALFA PLUS, DISOCLORINE
CHLOORTABLETTEN, Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex
Chloortabletten, Stafilex Combi, and Suma Tab D4 occurs during course spraying
by the professional user.
AEClocal dermal is 100 mg HOCl/L is equal to 0.01%
NaOCl. As mentioned before, the available chlorine from NaOCl is equivalent to
multiplication of the amount of NaOCl with MW (Cl2)/MW(NaOCl) =
71/74.4 = 0.95. Subsequently, 0.01%
NaOCl is equivalent to (0.1 g/L x 0.95 =) 0.095 g/L free chlorine. The maximum
doses of all products exceed the AEClocal dermal.
Correct use of personal protective equipment (gloves, coverall an face
visor) can reduce the dermal exposure results in a sufficient reduction of the
exposure to active chlorine during the application of all products except
Actisan-5L. For Actisan-5L, 2 layers of clothing (coverall + disposable
coverall with hood), boots, gloves and face visor, will result in a sufficient
reduction of the exposure to active chlorine during the application.
The operator can be inhalatory exposed to chlorine. AEClocal inhalation is
1.5 mg/m3 chlorine (based on a 15 min occupational health limit).
The maximum inhalatory exposure to chlorine per day is: occupational health
limit x breathing volume x time = 1.5 mg/m3 x 1.25 m3/h x
0.25 h = 0.46 mg/day. Based on the above used model (Spraying Model 1). In the
worst-case scenario (Actisan-5L, maximum diluted concentration of 6.0 g/L
active chlorine), the professional will be inhalatory exposed to 0.78 mg/day
chlorine (Table 2). This exceeds the maximum inhalatory exposure to chlorine
with a factor (0.78/0.46=) 1.7. However,
as produced chloride in solution reacts more easily with other molecules than
with chloride itself (which would lead to the formation of Cl2). The model used overestimates
the respiratory exposure to chlorine (a worst-case is shown, depicting the
situation where all active chlorine formed, results in the formation of Cl2).
Therefore, when used according to the WG/GA, it can be concluded that no
adverse health effects are expected for the unprotected professional user after
inhalatory exposure to chlorine as a result of the application of Actisan-5L.
The same conclusion applies for ALFA PLUS, DISOCLORINE CHLOORTABLETTEN,
Melquick, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex chloortabletten,
Stafilex Combi, and Suma Tab D4, as the diluted concentration of these products
is lower compared to P3-DISINFEKTO.
On the basis of the above
considerations, it can be concluded that the risk for the protected
professional user is acceptable (2 layers of clothing (coverall + disposable
coverall with hood), boots, gloves and face visor for Actisan-5L and coverall,
gloves and face visor for ALFA PLUS, DISOCLORINE CHLOORTABLETTEN, Melquick,
P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex Chloortabletten, Stafilex Combi,
and Suma Tab D4).
6.3.3
Non-professional users, including the general public
The non-professional user
can be exposed to products containing sodium dichloroisocyanurate (MELPOOL
55/G, MELPOOL 63/G, and Melquick) or a product containing trichlorocyanuric acid
(MELPOOL 90 TABLETTEN) during filling and maintenance of feeders of private
swimming pools.
Oral exposure is deemed
negligible as the user will not intently eat the product. All products are
either granules or in tablet form, therefore inhalatory exposure is negligible
and dermal exposure is the main route of exposure. However, as contact time to
the product is very short, the dermal exposure is deemed negligible compared to
the dermal exposure during use of the swimming pool.
On the basis of these considerations,
it can be concluded that the risk for the non-professional user for all
products is acceptable.
6.3.4
Indirect exposure as a result of use
Disinfection of milking equipment or surfaces in kitchens
As it is indicated in the
WG/GAs that after the treatment milking equipment and/or kitchen surfaces
should be rinsed with clean (tap) water, therefore it is not expected that
humans can be indirectly exposed to cyanuric acid and chlorine by eating foods
from kitchens and/or drinking milk from milking equipment that were treated
with: Actisan-5L, ALFA PLUS, DISOCHLORINE CHLOORTABLETTEN, Melquick, P3-ansep
chloortabletten, P3-DESINFEKTO, Stafilex Chloortabletten, Stafilex Combi and
Suma Tab D4. No residues in food and feeding stuffs are expected to arise from
the use of MELPOOL 55/G, MELPOOL 63/G, and MELPOOL 90 TABLETTEN.
Disinfections of accommodations and annexes for animals and/or means of
transport for animals
Actisan-5L, Melquick,
P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex chloortabletten and Suma Tab
D4 are used for the disinfection of accommodations and annexes for animals.
Furthermore, Actisan-5L, P3-ansep chloortabletten, P3-DESINFEKTO, Stafilex
chloortabletten and Suma Tab D4 are also used for the disinfection of means of
transport for animals. This means that livestock can be exposed to cyanuric
acid, HOCl and disinfection byproducts and that humans can be exposed
indirectly by consumption of animal products containing cyanuric acid, HOCl and
disinfection byproducts residues. However as it is indicated in the WG/GAs that
all products should be kept out of reach from animals, therefore it is not
expected that humans can be indirectly exposed to cyanuric acid, HOCl and
disinfection byproducts residues by the use of these products in as a animal
hygiene product (PT3).
Swimming pool
Dermal and oral exposure of
the general public to cyanuric acid and active chlorine will occur during use
of a swimming pool treated with Actisan-5L, MELPOOL 55/G, MELPOOL 63/G, and MELPOOL 90 TABLETTEN. Inhalation exposure
can be considered negligible as produced chloride in solution reacts more
easily with other molecules than with chloride itself (which would lead to the
formation of Cl2). It is
assumed that children will spend much more time in swimming pools than adults,
and accordingly will be the most exposed locally and systemically (also
compared to the professional/non-professional users). Therefore the exposure as
a result of use in swimming pools is only calculated for children.
Oral exposure
The following was taken
into account:
Table T.5 Chronic internal exposure to cyanuric acid
and active chlorine due to use of swimming pools causing systemic effects
|
Route |
Internal exposure (mg /day) a |
NL-AEL (mg/day) |
Risk-index b |
Swimming pool,
cyanuric acid |
||||
Child (4.5 years) |
Oral |
50 |
60.5 |
0.84 |
Dermal |
7 |
60.5 |
0.12 |
|
|
Total |
57 |
60.5 |
0.96 |
Swimming pool,
free chlorine |
||||
Child (4.5 years) |
Oral |
0.91 |
1.3 |
0.70 |
Dermal |
0.35 |
1.3 |
0.27 |
|
|
Total |
1.26 |
1.3 |
0.97 |
Swimming
pool, disinfection byproducts |
||||
Child (4.5 years) |
Oral |
<0.01 |
1.3 |
<0.01 |
Dermal |
<0.01 |
1.3 |
<0.01 |
|
|
Total |
<0.01 |
1.3 |
<0.01 |
a Internal
exposure was calculated with:
·
biological availability via
the oral route: 100% cyanuric
acids and 36.4% sodium chlorine
·
biological availability via
the dermal route: 10% (default for both cyanuric acid and sodium chlorine)
b The risk-index is calculated by dividing the
internal exposure by the AEL.
On the basis of the above
considerations, adverse health effects after oral and dermal exposure to
cyanuric acid, free chlorine and disinfection byproducts can be excluded.
Table T.6 Local external exposure to active HOCl due
to use of swimming pools causing local effects
Route |
external exposure (mg/L or mg/m3) |
AEC (mg/L or mg/m3) |
Risk-index b |
Swimming pool |
|||
Oral (mg HOCl/L) |
5a |
41 mg/L |
0.12 |
Dermal (mg HOCl/L) |
5a |
100 mg HOCl/L |
0.05 |
Inhalation (mg HOCl/m3) |
<<1b |
0.1 mg/m3 |
<<1 |
a Sodium
chlorine concentrations is calculated from available chlorine and the
multiplication with MW (NaOCl)/MW(Cl2) = 74.4/71 = 1.05.
b based on the
CAR Sodium bromide
On the basis of the above
considerations, it can be concluded that the risk for the swimmer is
acceptable.
6.3.5
Combined exposure
All products contain one
active substance, either sodium dichloroisocyanurate or trichlorocyanuric acid.
However, both active substances lead to cyanuric acid, active chlorine and
disinfection byproducts. The combined toxicological effect of these three
active substances has not been investigated with regard to repeated dose
toxicity.
Possibly, the combined
exposure to these active substances may lead to a different toxicological
profile than the profile(s) based on the individual substances. After cyanuric
acid, the urinary tract is affected, whereas exposure to chlorine affects the
liver, spleen and blood cell status.It is therefore not expected that combined
exposure to (residues of) all substances (i.e. cyanuric acid, active chlorine
and disinfection byproducts) will result in an additional risk above the
estimated risks based on the individual substances, when used in accordance to
the WG/GA.
6.4
Overall conclusions
Based on the risk
assessment, it can be concluded that the risk for the protected professional
user no adverse health effects are expected.
Protection should consist
of:
Furthermore, it can be
concluded that for the swimmer no adverse health
effects are expected.
Moreover, the WG/GA of all
products used to disinfect surfaces in private or public areas need to include
the following restriction: “fumigation is prohibited”.
6.5
Classification and labelling of the formulation
concerning health
6.5.1
Proposal for the classification of the active
substance
Sodium dichloroisocyanurate
Symbol: |
Xn |
Indication of danger:
Harmful |
Risk phrases |
R22 R36/37 |
Harmful if swallowed. Irritating to eyes and
respiratory system. |
Trichlorocyanuric acid
Symbol: |
Xn |
Indication of danger:
Harmful |
Risk phrases |
R22 R36/37 |
Harmful if swallowed. Irritating to eyes and
respiratory system. |
In Chapter 9 the complete
classification and labelling for the products are mentioned.
7.1 Introduction
A
prolongation of the authorisation is requested for the products Actisan-
The active substance sodiumdichloroisocyanurate consists of 2 entries for
annex I inclusion: Troclosene sodium (Sodiumdichloroisocyanurate anhydrate =
NaDCC) and Sodiumdihloroisocyanurate dihydrate (NaDCC-2H2O), which
differ only on the number of water molecules added to the active substance. It
is assumed that these water molecules do not participate in the toxicity of
Sodiumdihloroisocyanurate.
Trichlorocyanuric acid (TCCA or symclosene) also is an existing active
substance rather similar to sodiumdichloroisocyanurate, difference is a
chlorine molecule replacing the sodium molecule in sodiumdichloroisocyanurate.
Sodiumdichloroisocyanurate,
sodiumdihloroisocyanurate dihydrate and trichlorocyanuric acid are chlorinated
isocyanurates. Their mode of action consists in the release of chlorine and
formation of cyanuric acid as carrier. Therefore most endpoints are based on
read-across studies performed with cyanuric acid, hypochlorite and chlorine. It
is considered acceptable to combine the list of endpoints for all three active
substances.
Troclosene sodium, sodiumdihloroisocyanurate dihydrate and
trichlorocyanuric acid are existing active substances, not included in Annex I
of 98/8/EC. For all three active substances applications for inclusion are
submitted, for which the
The Board considers that sodiumdichloroisocyanurate and trichlorocyanuric
acid are a bulk chemicals (C157.4; May 2005), therefore accepts publicly
available data from IUCLID [2] and other data available at the CTGB [1]. Data
are included for the active substance Sodiumdihloroisocyanurate (NaDCC) and its
deactivated transformation product cyanuric acid (CYA). It should be noted that
these data have NOT been evaluated. There are no data available for the product
and this is not considered necessary.
The
risk assessment for proposed applications with active substance sodiumdichloroiso-cyanurate
and trichlorocyanuric acid is done in accordance with Chapter 10 of the RGB
[Transition period for guideline 98/08/EC] for products based on active
substances which have not been placed on Annex I of Directive 98/8/EC.
An
overview of the endpoints is included in the Appendix 1 with a profile of the
active substance sodiumdichloroiso-cyanurate (dihydrate), trichlorocyanuric
acid, the major transformation product cyanuric acid and hypochlorite. In
Appendix 2 an overview of the PNEC values is presented. In appendix 3 an
overview of all ESD calculations is included.
In
paragraph
The
products evaluated for prolongation are tablets or granulates for professional
use only, with the exception of applications in pools (professional and
non-professional users). The
intended use is described in table E.1., see Chapter 1.
7.2 Environmental exposure assessment
product
7.2.1
Chemistry
and/or metabolism
The chlorinated isocyanurates hydrolyse rapidly upon
addition to an aqueous environment (DT50
<1 minute) releasing free available chlorine. As the free available chlorine
is consumed by reaction with organic matter and inorganic ions (chlorine
demand), chloride ion is produced. The major stable degradation product is
cyanuric acid (CYA).
As residual product of the oxydation process
free available chlorine can be build in organic matter forming chlorinated
organic micro pollutants. These chlorinated organic micro pollutants are not
addressed in the environmental risk assessment, considering that these
residuals are formed in small quantities (<10% of the applied chlorine).
7.2.2
Distribution
in the environment
Emission routes
The
following lifecycle stages are considered:
Various
phases in the life cycle of a product may cause emissions and environmental
exposure. Emissions from active substance production and product formulation
are considered less relevant compared to emissions from the application phase,
in service and waste phase of the product.
Application, in-service and waste phase
Emission to
the environment during the application phase is only relevant for outdoor use
at farms for the disinfection of means of transport. All other applications,
including swimming pools are expected to have no emission to the environment
during the application and in-service phase.
Waste phase
Emissions
to the environment may occur during the waste phase when residuals of the use
biocidal product are removed:
- Indoor application of the product
in solutions to surfaces, materials or equipment after the prescribed contact
time results in the removal of residuals to the sewer with release to the STP.
- For indoor applications at farms
it is assumed that treated water with residuals of the biocidal product is
removed to Manure Storage Systems. Although the emission scenarios prepared by
the EU indicate that emission to the STP will occur. Release to and the
consequential exposure of the STP is not considered relevant for Dutch farming
as discharge of manure to the sewage system or on surface water is not
permitted.
- Applications to swimming pools may
result in removal of swimming water with residuals of the biocidal product to
the sewer. For larger swimming pools (outdoors) and private pools, however,
also direct emission to surface water occurs after drainage of the water.
- In
the waste phase the treatment of water of casks, buckets, vases for flowers (4)
(Actisan-
Emission to
the secondary compartments surface water/sediment via STP effluent depends on a
number of factors such as transformation / degradation of the a.s. and its
transformation products.
Emission to
air may occur during and after application of the product due to
ventilation.
Emission to
soil is considered negligible for applications with emission to the STP,
but relevant for applications at farms with direct emission to soil and
secondary emission to soil after spreading of manure with residuals of the
product. Also during the disinfection of animal transport vehicles at farms
emission to soil may occur.
The foreseeable routes of entry into the
environment during the application, in-service and waste phase are
listed in Table E.2.
Table
E.2. Foreseeable routes of entry into
the environment on the basis of the use envisaged
|
|
Environmental
compartments and groups of organisms exposed |
|||||
No |
Use
scenario |
STP |
Freshwater*
|
Saltwater* |
Soil** |
Air |
Birds
and mammals |
|
PT2 |
|
|
|
|
|
|
1. |
Accommodations for
people |
++ |
+ |
- |
- |
(+) |
(+)/- |
2. |
Areas/surfaces in
hospitals and health care facilities including medical instruments, cleaning
equipment, toilets etc. |
++ |
+ |
- |
- |
(+) |
(+)/- |
3. |
Therapeutic baths,
private pools (not part of hotels), camping sites, recreation centres or
boarding schools |
++ |
++ |
- |
- |
(+) |
(+)/- |
4. |
Water of casks,
buckets, vases for flowers |
++ |
+ |
- |
- |
- |
(+)/- |
|
PT3 |
|
|
|
|
|
|
5. |
Accommodations for
animals and annexes |
- |
- |
- |
+ |
(+) |
(+)/- |
6. |
Vehicles for animal
transport |
- |
- |
- |
++ |
(+) |
(+)/- |
|
PT4 |
|
|
|
|
|
|
7. |
Milking equipment on
farms, including pipelines, tanks, machinery etc. |
- |
- |
- |
+ |
(+) |
(+)/- |
8. |
Locations where food
and drinks are prepared or stored – surfaces, instruments, cleaning
equipment with (pt4) or without food
contact (pt2) |
++ |
+ |
- |
- |
(+) |
(+)/- |
++ Compartment
primarily exposed
+ Compartment secondarily
exposed (surface water from STP discharge, vertebrates eating contaminated fish
and soil after removal of manure with residuals of the product over grassland
and arable land)
(+) Compartment
potentially exposed
- Compartment
not exposed
(+)/- The
compartment is potentially exposed or not. This depends on the specific use and
the characteristics of the
active substance
* Including
sediment
** Including
groundwater, bees and non-target arthropods
It is
assumed that for indoor applications with emission to the sewer or manure
storage only the major transformation product cyanuric acid is relevant. The
active substance and active chlorine is consumed before reaching the STP or
soil.
Exposure of
the aquatic and/or soil compartment to the active substance / active chlorine
is relevant only for applications with outdoor use or direct emission to
aquatic compartment, such as outdoor treatment of applications in swimming
pools and means of animal transport.
It should
be noted that the several uses may result in simultaneous emission to the STP
and surface water. Therefore an accumulative risk assessment is considered
relevant.
Scenarios and models
used for PEC calculations
Predicted
Environmental Concentrations (PEC) for indoor and outdoor applications were
calculated in accordance with the scenarios from OECD Emissions Scenario
Documents (ESDs) for Private area and public health area disinfectants (RIVM,
2001), Draft final ESDs for Product Type 3: Veterinary hygiene biocidal
products, for Product Type 4: Disinfectants used in food and feed areas, Pt18
Insecticides for Stables and Manure Storage Systems. No EU scenario is
available for the treatment of water for flowers. Instead as worst case
assumption is used possible use of this product at flower auctions. Use in
flower greenhouses, transporters, sellers and consumers are expected to be more
diffuse, resulting in lower concentrations.
Calculations
were performed with excel sheets and EUSES 2.1. Input values, calculations and
results and can be found in appendix 3.
The ESD for
Stables and Manure Storage Systems assumes that the emission of the active
substance after application in animal housing occurs mainly via the
distribution of manure (agricultural land) and waste water (STP). The fractions
of the active substance that are emitted to those streams are determined by the
type of pest, the type of product, the methodology of product application, and
the type of housing and manure storage system.
The ESD
distinguishes 18 types of animal housings. Each type has its own
characteristics with respect to size, number of animals and fractions of the
active substance that are emitted via manure and/or waste water. All available
housing types were included in the present calculations. Considering all stable
types makes it possible to define restrictive measures per animal category or
stable type in case a potential risk is identified.
Manure is
spread on arable land once a year and on grassland 4x a year. The PIEC after a
single application of manure of land or grassland is calculated for both
scenarios using an excel sheet conform the ESD on treatment of manure in
stables. For grasslands, the PEC after four applications is calculated in addition
to the PIEC (conform the ESD).
7.2.3
PEC in
surface water, sediment and STP
Cyanuric
acid has only minor sorptive characteristics (Koc 108 L/kg). Therefore it is
considered that risks for the sediment are covered by the risk assessment for the aquatic compartment.
For the
application in swimming water of private pools Melpool 55/G, Melpool 63/G,
Melpool 90 Tabletten and Melquick direct emission to surface water may occur
after drainage of the treated swimming water. For uses such as public pools,
spas/hot tubs emission to the sewer and STP will occur. In table E-3 two tiers
are included: tier 1 is the environmental concentration in surface water if the
swimming water discharged immediately after treatment. In the second tier
deactivation of the active chlorine is taken into account a 1 day deactivation
period and assuming a DT50 of 4 hours. The latter value is considered realistic
considering that complete drainage of a swimming pool is carried out only if
the swimming water is aged and of low quality due to contaminants in the water.
It is expected that in such a water active chlorine is deactivated more
rapidly.
Table
E-3.
Use type |
Dilution factor |
Drainage |
|
|
|
PECaquatic, intermittent |
PECaquatic, intermittent [mg cyanuric acid/L] |
Tier 1: Discharge
immediate after treatment |
|||
Private pools |
2 |
2.5 |
50 |
Public pools |
4 |
1.25 |
25 |
Tier 2: Discharge after 3
day deactivation assuming a DT50 of 4 hours |
|||
Private pools |
2 |
9.54E-6 |
50 |
Public pools |
4 |
4.77E-6 |
25 |
Scenario 2 = Van der Poel and Bakker (2002)
A direct
quantitative risk assessment for the use of sodiumdichloroisocyanurate in water
of casks, buckets, vases for flowers is not possible, as no information is
available on the quantities used. The
product can be used in flower greenhouses, auctions, flower transporters,
sellers and consumers. It is expected that most emissions of treated water will
occur to the sewer with connection to a STP. Worst case application probably is
the use in flower auctions. As for the emission from flower auctions the
following data were derived from CBS: Discharge volume of 4 auctions per year:
3258.835 m3/year. Assuming 200 emission days results in a discharge
per auction of 4.1 m3/day. Assuming that 90% of the water is treated
results in a daily emission of
For the
proposed uses in private and public health area disinfectants (PT2), Veterinary
hygiene biocidal products (PT3) and food and feed area disinfectants (PT4)
indirect emission to surface water will occur. For this emission route the
assessment is restricted to the major transformation product cyanuric acid.
Table
E-4. Use of sodium dichloroisocyanurate (expressed as kg active chlorine /d)
and
No |
Use scenario |
Emission (kg/d) |
PECSTP (mg/L) |
PECsurface water (µg/L) |
|
PT2 |
|
|
|
1. |
Accommodations for people
(industrial and public) |
0.023 |
0.0067 |
0.67 |
2. |
Areas/surfaces in
hospitals and health care facilities including medical instruments, cleaning
equipment, toilets etc. |
0.21 |
0.061 |
6.1 |
3. |
Therapeutic baths, private
pools (not part of hotels), camping sites, recreation centres or boarding
schools |
2 |
0.59 |
59 |
4. |
Water of casks, buckets,
vases for flowers |
4.7 |
1.37 |
137 |
|
PT3 |
|
|
|
5. |
Accommodations for animals
and annexes |
- |
- |
- |
6.a |
Vehicles for animal
transport |
- |
- |
- |
|
PT4 |
|
|
|
7. |
Milking equipment on
farms, including pipelines, tanks, machinery etc. |
0.042 |
0.012 |
1.2 |
8a. |
Locations where food and
drinks are prepared or stored – surfaces, instruments, cleaning equipment* |
0.92 |
0.27 |
27 |
8b |
Beverage industry |
0.99 |
0.29 |
29 |
6.b |
vehicles for animal
transport (central disinfection) |
2.62 |
0.76 |
76 |
*: sum of
amounts used in slaughter houses and kitchens/canteens, without pre-treatment
**: Use in
beverage industry
As
described above all types of uses will result in emissions to the STP. The
Simple treat model in EUSES 2.1 was used to derive
- Henry’s Law
constant (3.79E-10 Pa*m³/mol)
- LogPow (1.95)
- biodegradability (inherently biodegradable)
7.2.4
PEC in air
See section
air under risk characterisation for the environment.
7.2.5
PEC in
soil and groundwater
The exposure assessment of cyanuric acid is based on the application of
manure to soil and the subsequent leaching to groundwater. Additionally a soil
exposure assessment is carried out for the disinfection of animal transport
vehicles at farms resulting in a direct emission to soil of product residues
including active chlorine and cyanuric acid.
The
risk assessment of soil is based on a worst case scenario that cyanuric acid did
not degrade in manure/slurry during storage. This is reasoned considering that
in the
The highest
PIEC soil in arable land and grassland 19.8 and 27.2 μg/kg soil see Table
E.5.
Table
E.5. PIECsoil and groundwater for cyanuric acid for arable and grassland after
treated manure application and PECsoil for active chlorine and cyanuric acid
after the disinfection of a animal transport vehicle at a farm, excluding
degradation.
Scenario |
Category |
Active chlorine |
Cyanuric acid |
|
|
|
Soil (mg/kg soil) |
Soil (mg/kg soil) |
Porewater (mg/L) |
Treated manure from stables# |
Arable land PIEC soil after one application |
0 |
1.98E-02
|
1.63E-4
|
|
Grassland PIECsoil after 4 applications |
0 |
2.76E-02
|
2.27E-4
|
Animal transport vehicles |
Soil after 1 disinfection treatment |
15.8 |
13.8 |
- |
# Worst case
maximum PIECsoil is directly after manure application on arable land;
The fate
and behaviour profile for cyanuric acid infers that it has a high potential to
reach groundwater as this compound has been shown to be mobile in soil. 4
scenarios of animal housings showed exceedance of the groundwater criteria for
drinking water by a factor of 1.6 to 2.3. It should be noted, that, although
not quantified, there are indications that cyanuric acid rapidly degrades under
anaerobic conditions. Considering the close range to acceptability of the
drinking water criterion for the 4 scenarios, fulfilment of the criterion for
14 scenarios, the uncertainties involved in the emission scenarios and the fact
that biodegradation is not included in the calculations, the risk for
groundwater used for the production of drinking water is considered
sufficiently addressed and considered acceptable.
7.2.6
Primary
and secondary poisoning of birds and mammals
The
estimated log Pow of sodiumdichloroisocyanurate, trichloroisocyanuric acid,
active chlorine and cyanuric acid are -0.05, not available and 1.95,
respectively. Which are far below the relevant trigger value of 3 as stated in
the TGD. It is concluded that the potential for sodiumdichloroisocyanurate,
trichloroisocyanuric acid and its major transformation products to
bio-accumulate is low and a risk of secondary poisoning does not exist.
Due the
type of use of the sodiumdichloroisocyanurate and trichloroisocyanuric acid
containing products primary poisoning is not expected to be of any relevance.
7.2.7
Monitoring
data
Monitoring
data of sodiumdichloroisocyanurate, trichloroisocyanuric acid, active chlorine
and cyanuric acid in water, soil and air compartments are not available.
7.3 Risk
characterisation for the environment
In
the risk assessment presented in this chapter a comparison is made between the
predicted environmental concentration (PEC), presented in the chapter above,
and the Predicted No Effect Concentration (PNEC). This PNEC is derived in
Appendix 2 from data available in the list of endpoints (Appendix 1). For the
different uses described above PEC/PNEC ratios are calculated. If the PEC/PNEC
ratio exceeds 1 then there is an unacceptable risk.
7.3.1 Aquatic
compartment (incl. Sediment) and STP
STP
The
proposed use may result in an emission of the active substance to the sewage
system, however, based on the rapid degradation, with a half life less than 2
minutes in activated sludge, it can be concluded that all active chlorine formed from sodiumdichloroisocyanurate or trichloroisocyanuric acid has
been decomposed by reductants present in the sewage drainage system. The active
chlorine will not reach the STP. Emission of the major transformation product
cyanuric acid to the STP will occur after use of sodiumdichloroisocyanurate or
trichloroisocyanuric acid containing products. The cyanuric acid concentration in the STP can only be derived
from the amount of product used.
Table
E.6. PEC/PNEC ratios of cyanuric acid for STP after emission (PNECSTP cyanuric
acid = 34 mg/L)
No |
Use scenario |
PECSTP (mg/L) |
PEC/PNEC |
|
PT2 |
|
|
1. |
Accommodations for people
(industrial and public) |
0.0067 |
<0.001 |
2. |
Areas/surfaces in
hospitals and health care facilities including medical instruments, cleaning
equipment, toilets etc. |
0.061 |
0.002 |
3. |
Therapeutic baths, private
pools (not part of hotels), camping sites, recreation centres or boarding
schools |
0.59 |
0.017 |
4. |
Water of casks, buckets,
vases for flowers |
1.37 |
0.04 |
|
PT3 |
|
|
5. |
Accommodations for animals
and annexes |
- |
- |
6.a |
vehicles for animal
transport |
- |
- |
|
PT4 |
|
|
7. |
Milking equipment on
farms, including pipelines, tanks, machinery etc. |
0.012 |
<0.001 |
8a. |
Locations where food and
drinks are prepared or stored – surfaces, instruments, cleaning equipment* |
0.27 |
0.008 |
8b |
Beverage industry |
0.45 |
0.008 |
6.b |
vehicles for animal
transport (central disinfection) |
0.76 |
0.022 |
|
Accumulative exposure |
|
0.099 |
*: sum of amounts used in slaughter houses and
kitchens/canteens, without pre-treatment
No
unacceptable risks for micro-organisms in the STP are expected (even if all
emissions are combined to one STP). Therefore the standard for micro-organisms
in the STP is met for all products and applications.
Water and sediment organisms
The
risk of direct emission of formed active chlorine and cyanuric acid to surface
water formed after the application of sodiumdichloroisocyanurate or
trichloroisocyanuric acid to swimming water is assessed in table E.7.
Table
E.7 PEC/PNEC ratios of active chlorine and cyanuric acid in surface water after
direct emission of treated pool water
No |
Use scenario |
PECsurface water (µg/L) |
Acute PNEC (µg/L) |
PEC/PNEC |
Discharge immediately after treatment |
||||
|
active chlorine |
2500 |
0.3 |
8333 |
|
cyanuric acid |
50,000 |
6600 |
7.6 |
|
Combination toxicity |
|
|
8340 |
Discharge after 3 days deactivation assuming a
DT50 of 4 hours |
||||
|
active chlorine |
0.0095 |
0.3 |
0.03 |
|
cyanuric acid |
50,000 |
6600 |
7.6 |
|
Combination toxicity |
|
|
7.63 |
Direct
emission to surface water of treated swimming water from will result in a short
term risk for aquatic organisms. Deactivation of the active chlorine will
result in a lower risk, but the risk is still unacceptable for the emission of
cyanuric acid remaining in the emitted swimming water.
An
overview of the risks due to indirect emission of sodiumdichloroisocyanurate or
trichloroisocyanuric and its major transformation products to water and
sediment organisms after discharge of wastewater through a STP is presented
below.
No
direct or indirect exposure of STP, surface water and sediment is expected from
indoor applications of the product of the product in animal housings.
Table
E-8. PEC/PNEC ratios of cyanuric acid in surface water after indirect emission
via the STP (PNEC cyanuric acid = 660 µg/L).
No |
Use scenario |
PECSW (µg/L) |
PEC/PNEC |
|
PT2 |
|
|
1. |
Accommodations for people
(industrial and public) |
0.67 |
0.001 |
2. |
Areas/surfaces in
hospitals and health care facilities including medical instruments, cleaning
equipment, toilets etc. |
6.1 |
0.009 |
3. |
Therapeutic baths, private
pools (not part of hotels), camping sites, recreation centres or boarding
schools |
59 |
0.089 |
4. |
Water of casks, buckets,
vases for flowers |
137 |
0.21 |
|
PT3 |
|
|
5. |
Accommodations for animals
and annexes |
- |
- |
6.a |
Vehicles for animal
transport |
- |
- |
|
PT4 |
|
|
7. |
Milking equipment on
farms, including pipelines, tanks, machinery etc. |
1.2 |
0.002 |
8a. |
Locations where food and
drinks are prepared or stored – surfaces, instruments, cleaning equipment* |
27 |
0.041 |
8b |
Beverage industry |
29 |
0.044 |
6.b |
Vehicles for animal
transport (central disinfection) |
76 |
0.12 |
|
Accumulative exposure |
|
0.52 |
*: sum of amounts used in slaughter houses and
kitchens/canteens, without pre-treatment
No
unacceptable risks for aquatic organisms in surface water are expected (even if
all emissions are combined to one STP discharging to surface water). Therefore
the criterion for aquatic organisms in water is met for all products and
applications.
Monitoring data (surface water)
There are
no data available in the Pesticide Atlas regarding the presence of sodiumdichloroiso-cyanurate or trichloroisocyanuric and major transformation products
active chlorine and cyanuric acid in surface water.
All
products evaluated here are on the market for more than 3 years (First product
is authorised since 18-January-1991). From the general
scientific knowledge collected by the Ctgb about the product, its active
substance and major transformation products, the Ctgb concludes that there are
no concrete indications for concern about the consequences of this product for
surface water from which drinking water is produced when used in compliance
with the directions for use. The Ctgb does not expect an exceeding of the drinking
water criterion when the product is used conform the Legal instructions for
Use. The standards for surface water destined for the production of drinking
water are met.
7.3.2 Atmosphere
Criteria
for the examination of environmental risks to air are not specified by a
numerical standard. Therefore, effects on air quality are only taken into
account when adverse effects are predicted.
Currently, the assessment of potential impacts on air quality is aimed
to minimise the risk for stratospheric ozone depletion.
Within
the NL framework, the following approach is used to test for ozone depletion:
The
WGB admission requirements for air can be considered as generic, without a
quantitative assessment. As possible effects to the air quality are
qualitatively determined only, the assessment is restricted to the evaluation
of the potential of the active substances regarding their potential to deplete
ozone in the earth’s stratosphere (ozone layer).
The
FOCUS air working group developed a guidance methodology to determine the
potential of a substance for ozone depletion. The following issues are
considered relevant:
1. the atmospheric life time of a substance should be long enough
to transport the substance to the atmosphere;
2. The substance contains one or more of the following
substituents: F, Cl of Br;
3. Substances containing N and S are relevant in stratospheric
ozone depletion (e.g. N2O);
Exemplified
substances are CFCl3, tetrachloromethane, HCFC142b, Halon 1211 and
methyl bromide with a atmospheric life time of 2 to 50 year.
As
sodiumdichloroisocyanurate and trichloroisocynuric acid fulfils one of these
criteria, a potential risk for ozone depletion may occur. It depends on the
type of use, emission route and possible other degradation characteristics,
whether ozone depletion is relevant.
A
source of chlorine is from the use of sodiumdichloroisocyanurate and
trichloroisocynuric acid in indoor disinfection treatments and in swimming
pools. When released, this chlorine is rapidly converted to forms that dissolve
in water and therefore are removed from the lower atmosphere. Such chlorine
never reaches the stratosphere in significant amounts [WHO reporting}.
Therefore
the proposed application of the active substances sodiumdichloroisocyanurate
and trichloroisocynuric acid meet the standards for air.
7.3.3 Terrestrial compartment
Soil organisms
The
risk assessment is targeted to the risks for soil organisms after exposure to
treated manure and direct emission to soil of product residues during
disinfection treatment of animal transport vehicles on farms.
Table
E.9. PIECsoil and PEC/PNEC for cyanuric acid for arable and grassland after
treated manure application and PECsoil and PEC/PNEC for active chlorine and
cyanuric acid after the disinfection of a animal transport vehicle at a farm.
Scenario |
Category |
Active
chlorine |
Cyanuric acid |
||
|
|
Soil (mg/kg soil) |
PEC/PNEC |
Soil (mg/kg soil) |
PEC/PNEC |
Treated manure from stables# |
Arable land PIEC soil after one application |
- |
- |
1.98E-02 |
0.001 |
|
Grassland PIECsoil after 4 applications |
- |
- |
2.76E-02 |
0.015 |
Animal transport vehicles |
Soil after 1 disinfection treatment |
15.8 |
** |
13.8 |
7.7 |
# Worst case
scenario: maximum PIECsoil directly after manure application on arable land and
grassland;
** Risk could not be determined because no
PNECsoil could be derived for active chlorine.
PECsoil/PNECsoil
quotients were below
Non-target arthropods (including
bees)
The
exposure of bees is considered negligible as bees are not considered to forage
in animal housings or on manure treated land. Soil dwelling arthropods are
considered to be covered by the risk assessment for soil organisms as cyanuric
acid is assumed to have a non-specific mode of action.
All
other uses as described in table E.1 are not expected to result in exposure of
non-target arthropods (including bees). Therefore risks for non-target
arthropods including bees are considered acceptable for all uses.
Groundwater
Assessment
of the drinking water criterion takes place according to the RGB. This means
that the concentration of the active substance and relevant metabolites in
groundwater for the preparation of drinking water needs to be < 0.1
μg/L.
The
PECgw derived using the equilibrium partitioning method from the PEC soil,
estimated that for arable and grasslands, the cut off value of 0.1 µg/L would
be exceeded for all animal housings and that a higher tier risk assessment was
necessary.
Also
Persistence in soil
Sodiumdichloroisocyanurate
and trichloroisocynurate react
rapidly with organic and inorganic material in soil and will not persist. Both
actives meet the standards for persistence. No soil degradation studies are available for
major transformation product cyanuric acid. Cyanuric acid is considered to be
not readily biodegradable in laboratory studies (OECD, 1999). However, it does
biodegrade in the environment, in both soil and ambient water systems, in which
it degrades to carbon dioxide and ammonia so that it does not accumulate in the
environment. The standards for persistence in soil are met.
7.3.4 Non compartment specific effects relevant to
the food chain
Bioconcentration and
secondary poisoning
As the log
Kow values are < 3 for sodiumdichloroisocyanurate and cyanuric
acid (-0.05 and 1.95, respectively), and as active chlorine is a reactive short
living substance, a risk for bioconcentration and biomagnification is not
expected (conform the biomagnification trigger value proposed for Kow
in the TGD).
The
risk for bioconcentration and secondary poisoning in the proposed use is
therefore considered not relevant. The standards for bioconcentration and
secondary poisoning are met.
Primary poisoning of
birds and mammals
The
proposed use will not result in direct exposure of birds and mammals and thus
the risk for the primary poisoning is considered acceptable.
7.4 Measures
to protect the environment (risk mitigation measures)
Additional
measures to protect the environment (risk mitigation measures) are required for
applications related to the direct discharge of swimming water. The following
mitigation measure is required for the application in swimming water of private
and public pools of Melpool 55/G, Melpool 63/G, Melpool 90 Tabletten and
Melquick: “To protect aquatic organisms direct discharge of the treated
swimming water must be prevented”.
“Om in het water levende organismen te beschermen dient voorkomen te worden dat zwemwater of afvalwater met middelresten rechtstreeks op het oppervlaktewater wordt geloosd.”
Additional
measures to protect the environment (risk mitigation measures) are required for
applications related to the direct emission to soil after disinfection of
animal transport vehicles at farms. The following mitigation measure is
required for Actisan 5L, P3-Desinfekto, P3-ansep Chloortabletten, Stafilex
Chloortabletten, Suma Tab D4: “To prevent adverse effects for soil organisms
disinfection of animal transport vehicles is restricted to locations with a
hard standing with a discharge to a sewer system connected to a STP”.
“Ter voorkoming van nadelige effecten voor bodemorganismen dient de desinfectie van dier transportmiddelen te worden uitgevoerd op locaties met een verharde ondergrond met afvoer naar een riool met aansluiting op de RWZI.”
7.5
Overall conclusion
It can be
concluded that:
Based on
the available data, it can be concluded that Actisan-
Data
requirements
There are
no additional data required.
CONSULTED LITERATURE SOURCES
Ctgb dossier |
|
EUSES 2.1.1 |
|
Pearl 3.3.3 |
|
ESD |
for PT2, 3 and 4 |
WHO |
[3] WHO, 2007. Sodium Dichloroisocyanurate in
Drinking-water - Background document for development of WHO Guidelines for
Drinking-Water Quality |
When the products Alfa Plus, Actisan-
Actisan
5-L, 8960 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N |
Indication
of danger: |
Harmful, Dangerous
for the environment |
|||
R phrases |
R22 R31 R36/37 R50/53 |
Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to eyes and respiratory system. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S26 S36/37/39b S60 S61 |
Keep
container dry. When
using do not smoke. In case
of contact with eyes, rinse immediately with plenty of water and seek medical
advice. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid
release to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
Disochlorine chloortabletten, 11292 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N |
Indication
of danger: |
Harmful, Dangerous
for the environment |
|||
R phrases |
R22 R31 R36/37 R50/53 |
Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to eyes and respiratory system. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S26 S36/37/39b S60 S61 |
Keep
container dry. When using
do not smoke. In case
of contact with eyes, rinse immediately with plenty of water and seek medical
advice. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid release
to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
MELQUICK 8813 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N O |
Indication
of danger: |
Harmful, Dangerous
for the environment Oxidizing |
|||
R phrases |
R8 R22 R31 R36/37 R50/53 |
Contact
with combustible material may cause fire. Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to eyes and respiratory system. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S26 S36/37/39b S60 S61 |
Keep
container dry. When
using do not smoke. In case
of contact with eyes, rinse immediately with plenty of water and seek medical
advice. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid
release to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
P3-ansep
chloortabletten, 6377 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N O |
Indication
of danger: |
Harmful, Dangerous
for the environment Oxidizing |
|||
R phrases |
R8 R22 R31 R36/37 R50/53 |
Contact
with combustible material may cause fire. Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to eyes and respiratory system. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S26 S36/37/39b S60 S61 |
Keep
container dry. When
using do not smoke. In case
of contact with eyes, rinse immediately with plenty of water and seek medical
advice. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid
release to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
P3-desinfecto, 6571 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N, O |
Indication
of danger: |
Harmful, Dangerous
for the environment Oxidizing |
|||
R phrases |
R8 R22 R31 R37/38 R41 R50/53 |
Contact
with combustible material may cause fire. Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to respiratory system and skin. Risk of
serious damage to eyes. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S26 S36/37/39b S60 S61 |
Keep
container dry. When
using do not smoke. In case
of contact with eyes, rinse immediately with plenty of water and seek medical
advice. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid
release to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
Stafilex
Chloortabletten, 6706 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N |
Indication
of danger: |
Harmful, Dangerous
for the environment |
|||
R phrases |
R22 R31 R36/37 R50/53 |
Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to eyes and respiratory system. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S22/23-NL S36/37/39b S60 S61 |
Keep
container dry. When
using do not smoke. Do not
breath dust and spray. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid
release to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
Suma Tab
D4, 7321 N
Substances, present in the
formulation, which should be mentioned on the label by their chemical name
(other very toxic, toxic, corrosive or harmful substances): |
||||||
- |
||||||
Symbol: |
Xn, N O |
Indication
of danger: |
Harmful, Dangerous
for the environment Oxidizing |
|||
R phrases |
R8 R22 R31 R36/37 R50/53 |
Contact
with combustible material may cause fire. Harmful
if swallowed. Contact
with acids liberates toxic gas. Irritating
to eyes and respiratory system. Very
toxic to aquatic organisms, may cause long-term adverse effects in the
aquatic environment. |
||||
|
|
|
||||
S phrases |
S8 S21 S22/23-NL S36/37/39b S60 S61 |
Keep
container dry. When
using do not smoke. Do not
breath dust and spray. Wear
suitable protective clothing, gloves and face protection. This
material and its container must be disposed of as hazardous waste. Avoid
release to the environment. Refer to special instructions/safety data sheets. |
||||
|
|
|
||||
Special
provisions: |
- |
- |
||||
Child-resistant fastening
obligatory? |
n/a |
|||||
Tactile
warning of danger obligatory? |
n/a |
|||||
The current
classification and labelling, which are prepared in conformity with Directive
1999/45/EC, can be maintained for the products:
Alfa Plus,
Melpool 55/G, Melpool 63/G, Stafilex Combi and Melpool 90 Tabletten.
No references are available.
This List of endpoints contains studies not evaluated by the CTGB as
these are currently under assessment as part of the EU BPD Annex I inclusion
process.
Profile
of active substance
Identity
Chemical name (CA) |
Troclosene sodium = Sodiumdihloroisocyanurate
anhydrate (NaDCC) Sodiumdihloroisocyanurate dihydrate (NaDCC-2H2O)
Trichloroisocyanuric acid (TCCA), |
CAS No |
2893-78-9 51580-86-0 87-90-1 |
Molecular formula |
C3C12N3O3.Na C3Cl2N3O3.2H2O.Na C3Cl3N3O3 |
Molecular mass |
Troclosene sodium: 219.95 Sodium dichloroisocyanurate
dihydrate: 255.98 TCCA 232.41 |
Structural formula |
Troclosene sodium TCCA Sodium dichloroisocyanurate dihydrate CYA (transformation product): |
Physical
and chemical properties
Appearance (state purity) |
White
granular solid with chlorine odour |
Specific gravity |
Sodium
dichloroisocyanurate dihydrate: 1.97 g/mL at CYA: 1.75 g/mL |
Vapour pressure (in Pa, state temperature) |
< 0.06
Pa at 20 ºC |
Henry’s law constant |
5.28 E-05
atm-m3/mole fraction (calculated) 5.35 Pa-m3/mole TCCA <0.002 Pa at |
Solubility in water (g/l or mg/l, state
temperature) |
The active substance hydrolyses rapidly upon
addition to water. The results of the study therefore reflect the hydrolysis
reaction and the resultant solubility of the hydrolysis products. Troclosene
sodium: 15000
mg/L (10°C) 20000
mg/L (20°C) 28000
mg/L (30°C) |
|
Sodium
dichloroisocyanurate dihydrate: 17000 mg/L
(10°C) 22500
mg/L (10°C) 31000
mg/L (10°C) |
Partition coefficient (log POW) |
Log Pow =
-0.0556 TCCA: Log Pow = 0.94 The
substance is a salt which hydrolyses rapidly in water (t1/2 < 1
second) forming polar products which are insoluble in octanol and soluble in
water, which suggests that the Pow would be very low. The
active substance reacts with octanol.. |
Route
and rate of degradation in water
Hydrolysis of active substance and relevant
metabolites (DT50) (state pH and temperature) |
Chlorinated isocyanurate t½ < 1 minute CYA t½ > 30 days at 25% at all
environmentally relevant pH |
Photolytic / photo-oxidative degradation of
active substance and resulting relevant metabolites |
CYA t½ > 30 days at |
Readily
biodegradable (yes/no) |
TCCA or NaDCC – No, inherently biodegradable CYA – No. CYA degrades rapidly under anaerobic
conditions (soils, sediments) or under conditions of low dissolved oxygen.
(100% degradation in activated sludge (2.5 mg/l O2) in 8 hours) |
Biodegradation
in seawater |
Not
applicable |
Non-extractable
residues |
Not
applicable |
Distribution in water / sediment systems
(active substance) |
TCCA or NaDCC undergoes rapid hydrolysis to
form available chlorine in the form of HOCl and cyanuric acid. |
Distribution in water / sediment systems (metabolites) |
Available chlorine will be rapidly reduced by
organic matter, the stable reaction products are CYA or its salts and
chloride salts. CYA degrades under a wide variety of natural
conditions, and particularly well in systems of either low or zero dissolved
oxygen, such as anaerobic activated sludge and sewage, soils, mud’s, etc. The
overall degradation reaction is hydrolysis, initially to carbon dioxide and
ammonia. Since no net oxidation occurs, CYA exerts no primary biological
oxygen demand. However, eventual nitrification of the ammonia would exert its
usual biological oxygen demand. Organisms degrading CYA under anaerobic
conditions do not require acclimatisation. In highly aerobic media, CYA resists
biodegradation. |
Route
and rate of degradation in soil
Mineralization (aerobic) |
Not performed – not applicable to the
proposed product types. |
Laboratory studies (range or median, with
number of measurements, with regression coefficient) |
Not performed |
Field studies (state location, range or median with number of measurements) |
Not performed |
Anaerobic degradation |
CYA degrades readily under a wide variety of
natural conditions, and particularly well in systems of either low or zero
dissolved oxygen, such as anaerobic activated sludge and sewage, soils, muds
(Saldick J (1974) 100% degradation in farm soil in 23 days. |
Soil photolysis |
No data available |
Non-extractable residues |
No data available |
Relevant metabolites - name and/or code, % of
applied a.i. (range and maximum) |
No data available |
Soil accumulation and plateau concentration |
CYA degrades readily under a wide variety of
natural conditions, and particularly well in systems of either low or zero
dissolved oxygen, such as anaerobic activated sludge and sewage, soils,
mud’s, etc. The overall degradation reaction is hydrolysis, initially to
carbon dioxide and ammonia. Since no net oxidation occurs, CYA exerts no
primary biological oxygen demand. However, eventual nitrification of the
ammonia would exert its usual biological oxygen demand. Organisms degrading
CYA under anaerobic conditions do not require acclimatisation. |
Adsorption/desorption |
|
Ka , Kd Kaoc , Kdoc pH dependence (yes / no) (if yes type of dependence) |
Performed on CYA Kd = 0.114 – 0.622 Koc = 8 – 150 No. TCCA or NaDCC is rapidly reduced by reaction
with inorganic species in soil. Mobility of CYA decreases with decreasing
organic matter. |
Fate
and behaviour in air
Direct photolysis in air |
No absorbance in the UV at < 290 nm Indirect photolysis with OH radicals
(TCCA/NaDCC/CYA) = 43 hours with an overall OH rate constant of 3.00 E-12 cm3/molecule-sec
(calculated, EPIWIN v 3.12) |
Quantum yield of direct photolysis |
No data available |
Photo-oxidative degradation in air |
Latitude:
............. Season:
................. DT50.............. |
Volatilization |
The active substance is not volatile;
however, available chlorine and chloride will be released when the active
substance is in the aqueous environment, therefore small emissions of
chlorine compounds (HOCl and chloramines) to the air compartment would be
expected during use of the substance. These compounds are very short-lived
due to their high reactivity, therefore there is insignificant risk. The
lifetime of HOCl in the stratosphere under photolysis conditions is at most
30 min. The amount of chloride released from use of these compounds is
insignificant compared to natural sources. |
Monitoring data, if available |
|
Soil (indicate location and type of study) |
No data available |
Surface water (indicate location and type of
study) |
No data available |
Ground water (indicate location and type of
study) |
No data available |
Air (indicate location and type of study) |
Monitoring data from a single manufacturing
site has shown that the actual exposure is 0.1 ppm (0.145 mg/m3)
chlorine. |
Chapter 5: Effects on
Non-target Species
Toxicity data for aquatic species (most sensitive species of each
group) CYA |
|
||||||
Species |
Time-scale |
Endpoint |
Toxicity |
|
|||
Fish |
|
||||||
Salmo gairdneri |
96h |
LC50 |
>2100 mg/L of CYA measured/nominal |
|
|||
Salmo gairdneri |
21 days |
NOEC |
= 756 mg/L of CYA measured/nominal |
|
|||
Invertebrates |
|
||||||
Daphnia magna |
48 hr |
EC50 |
> 1000 mg/L of CYA measured/nominal |
|
|||
Daphnia magna |
21 day |
NOEC |
= 121 mg/L of CYA measured/nominal |
|
|||
Algae |
|
||||||
Selenastrum
capricornutum |
96 hr |
EC50 |
= 655 mg/L of CYA measured/nominal |
|
|||
N.
pelliculosa |
96 h |
NOEC |
= 945 mg/L of CYA measured/nominal |
|
|||
Microorganisms |
|
||||||
Activated sludge, predominantly domestic
sewage |
3 h |
EC50 |
= 3402 mg/L of CYA |
|
|||
Toxicity data for aquatic species (most sensitive species of each
group) NaDCC
|
|
||||||
Species |
Time-scale |
Endpoint |
Toxicity |
|
|||
Fish |
|
||||||
Salmo gairdneri |
96 h |
LC50 |
0.22 mg/L [2] |
|
|||
Invertebrates |
|
||||||
Daphnia magna |
48 hr |
EC50 |
0.196 µg/L
of NaDCC anhydrous nominal [2] |
|
|||
Daphnia magna |
48 hr |
EC50 |
0.28 mg/L [2] |
|
|||
|
|
|
|
|
|||
Algae |
|
||||||
No data available |
|
|
|
|
|||
Microorganisms |
|
||||||
No data available |
|
|
|
|
|||
Toxicity data for aquatic species (most sensitive species of each
group)
Trichloroisocyanuric acid (TCCA) |
|||||||
Species |
Time-scale |
Endpoint |
Toxicity |
||||
Fish |
|||||||
Salmo gairdneri |
96h |
LC50 |
0.24 mg/L of TCCA nominal |
||||
Lepomis macrochirus |
96h |
LC50 |
>
0.23 mg/L of TCCA nominal |
||||
Oryzias latipes |
96h |
LC50 |
0.3 mg/L TCCA [2] |
||||
Invertebrates |
|||||||
Daphnia magna |
48 hr |
NOEC |
= 0.21 mg/L of TCCA measured/nominal |
||||
Daphnia magna |
48 hr |
NOEC |
0.17 of TCCA measured/nominal |
||||
Daphnia magna |
48h |
EC50 |
0.21 mg/L TCCA [2] |
||||
Algae |
|||||||
Chlorella pyrenoidosa. Euglena gracilis, Scenedesmus
obligauus |
96 hr |
EC50 |
= 655 mg/L of CYA measured/nominal 0.5 mg/L TCCA nominal |
||||
Microorganisms |
|||||||
Activated sludge, predominantly domestic
sewage |
3 h |
EC50 |
= 59 mg/L of TCCA |
||||
Effects
on sediment dwelling organisms
Acute toxicity to |
CYA is not toxic to chironomid. NOEC = 756
mg/kg wwt |
Effects
on earthworms or other soil non-target organisms
Acute toxicity to …………………………………. |
CYA is not toxic to earthworms. NOEC = 756
mg/kg wwt |
Reproductive toxicity to ………………………… |
No data available |
Effects
on soil micro-organisms
Nitrogen mineralization |
No data available |
Carbon mineralization |
No data available |
Effects on terrestrial vertebrates
Acute toxicity to mammals |
NaDCC dihydrate: LD50 = 2094 mg/kg bw (male) LD50 = 1671 mg/kg bw (female) TCCA: LD50 = 787 mg/kg bw (male) CYA > 5000 mg/kg bw |
Reproductive toxicity to mammals |
Performed on cyanuric acid NOEL = 5375 ppm (470 – 500 mg/kg bw/day males
only) offspring NOAEL adult toxicity (F2 generation) = 190
mg/kg bw/day, males only |
Acute toxicity to birds |
No data available |
Dietary toxicity to birds |
NaDCC is not toxic to birds. LD50 = 1766
mg/kg TCCA is not toxic to birds. LD50 = 1630 mg/kg |
Reproductive toxicity to birds |
No data available |
Effects
on honeybees
Acute oral toxicity |
No data available |
Acute contact toxicity |
No data available |
Effects
on other beneficial arthropods
Acute oral toxicity |
No data available |
Acute contact toxicity |
No data available |
Acute toxicity to ……………………………….. |
No data available |
Bioconcentration |
|
Bioconcentration factor (BCF) |
The chlorinated isocyanurates react rapidly
in aqueous solutions releasing free available chlorine, therefore the Log Pow
of any of the chlorinated isocyanurates are expected to be low. The
calculated Log BCF for NaDCC is 0.286 (BCF = 1.932). If absorbed, the
available chlorine will readily react with proteins in tissue to form
oxidized proteins, chloride ion and CYA. The measured Log Pow of the CYA is
-1.31 giving a calculated Log BCF of 0.500 (BCF = 3.162). Therefore, there is
no potential for bioaccumulation. |
Depuration time (DT50) (DT90) |
Not measured |
Level of
metabolites (%) in organisms accounting for > 10
% of residues |
None |
Input parameters for cyanuric acid in EUSES and
Parameter |
Input |
Unit |
d/s/o* |
Molecular weight |
128 |
g/mol |
s |
Melting point |
193 |
oC |
s |
Boiling point |
458 |
oC |
s |
Vapour pressure |
5.87E-9 |
Pa at 25 oC |
s |
Water solubility |
2E+03 |
Mg/L at 25 oC |
s |
Octanol water partitioning coefficient |
1.95 |
L/kg |
s |
Koc |
108 |
L/kg |
o |
Henry’s law constant |
3.79E-10 |
Pa.m3.mol-1 |
o |
Biodegradation |
Inherently
biodegradable DT50 300 |
-[d] at 12oC |
s |
d=default;
s=set; o=calculated.
Active chlorine
Toxicity for aquatic organisms:
Ecotoxicological data free available / active chlorine (FAC) are mainly
available from open literature. In de RAR of RMS Italy (November 2007) an
overview of the endpoints available in the open literature concerning the
toxicity to aquatic organisms, see the table presend below.
SUMMARY OF ECOTOXICITY DATA SELECTED FOR THE DETERMINATION OF THE PNEC
FOR FRESHWATER ORGANISMS
SHORT-TERM TOXICITY |
||||
|
Valid
data |
Supportive
information |
||
|
Endpoint |
Study
Details/Reference |
Endpoint |
Study
Details/Reference |
Fish |
- |
|
96-168h LC50 =
60-33 μg TRC/l >30 - > 16.5
μg FAC/l (FAC >
50%) |
(intermittent
exposure, 40'x3 times/d) (Heath, 1977, 1978) |
Crustaceans
(Ceriodaphnia) |
24h LC50 = 5 μg FAC*/l (rated 2) |
|
|
|
Algae |
- |
|
- |
|
LONG –TERM TOXICITY |
||||
|
Valid
data |
Supportive
information |
||
Fish |
- |
|
134d NOEC = 5 μg TRC/l No FAC specified. |
growth (field
study) (Hermanutz et al., 1990) |
Crustaceans |
- |
|
- |
|
Mollusks
(bivalves) |
- |
|
36d 100% mortality |
50 μg TRC/l |
|
|
|
|
|
Algae |
7d NOEC = 3 μg TRC/l (rated 2) 2.1 μg FAC/l (FAC 73%) |
Biomass (microcosm study)
(Cairns et al., 1990) |
28d EC50 = 2.1 μg TRC/l 2.1 μg FAC/l (FAC (100%) |
Biomass (microcosm
study) (Pratt et al., 1988) |
Mesocosm study |
|
|
24d NOEC = 1.5 μg TRC/l (rated 2) 1.5 μg FAC/l (FAC 100%) |
(zooplankton density) (Pratt et
al., 1988) |
FAC = (free available chlorine)
TRC = total residual chlorine
*FAC
as HOCl
rates: 1 = valid
2 = valid with restriction
s = supportive information
RIZA determined an ad hoc chronic MTR of 0.3 mg active
chlorine /L, which is in line with the available data presented above and used
in the risk assessment.
[3] Fate of sodium dichloroisocyanurate in (drinking)
water
When
added to water, NaDCC (anhydrous or dihydrate) rapidly hydrolyses to release
Free Available Chlorine FAC and establish a complex series of equilibria
involving six chlorinated and four non-chlorinated isocyanurates. These
equilibria are established on the order of seconds (Matte et al., 1989). The
concentration of each species depends on the concentrations of total available
chlorine (TAC = FAC plus “reservoir” chlorine, e.g. as DCC−) and total
isocyanurates, the pH and the values of the equilibrium constants (dependent on
temperature and ionic strength). “Reservoir” chlorine refers to the bound
chlorine of the various chloroisocyanurates. The latter function as reservoirs
of rapidly released FAC, as FAC is depleted. Thus, if hypochlorous acid is
consumed by reaction with organic material (oxidation), chloroisocyanurates
will rapidly dissociate to release more hypochlorous acid.
The
FAC for anhydrous NaDCC (commercial product) is 62–64%, and the dihydrate has
55–56% FAC; the FAC for elemental chlorine is 100% (Pinto & Rohrig, 2003).
Therefore,
development of 1 mg of FAC per litre, typical for drinking-water treatment,
requires approximately 1.6 mg of anhydrous NaDCC per litre and approximately
1.8 mg/l for the dihydrate. The distribution of the various chemical species in
aqueous solutions of NaDCC can be calculated from their hydrolysis and acid
dissociation constants. As an example (OxyChem, 1997), dissolution of NaDCC to
provide 1.0 mg of TAC per litre, at pH 7.0, gives the following: 48.1% TAC from
hypochlorous acid, 26.8% TAC from monochlorocyanurate, 11.8% TAC from
dichlorocyanurate, 12.8% TAC from hypochlorite and less than 1% from other
chlorocyanurates and chlorocyanuric acids.
In
normal batch-type use of NaDCC, oxidative and microbiocidal demand will consume
FAC until all available chlorine has been reduced, leaving only nonchlorinated
isocyanurates/cyanurate (e.g. cyanuric acid). As long as NaDCC is added to
water to maintain a certain level of TAC or FAC, however, the various cyanurates
will be present at levels dependent on the properties of the water (i.e. pH,
temperature, etc.) (Kuznesof, 2003).
Cyanuric
acid is considered to be not readily biodegradable in laboratory studies (OECD,
1999). However, it does biodegrade in the environment, in both soil and ambient
water systems, in which it degrades to carbon dioxide and ammonia so that it
does not accumulate in the environment (Saldick, 1975; Jessee et al., 1983; de
Souza et al., 1998; Ghosh & Philip, 2006; Satsuma, 2006; Shiomi et al.,
2006).
The RGB requires that the environmental risk is assessed on basis of
Predicted No Effect Concentrations (PNEC), which determined in line with the Technical
Guidance document (version 2003 chapter 3). PNEC values for the different
compartments are derived from ecotoxicity data and applying assessment factors.
Depending on the type of data (acute or chronic) and number of data a certain
assessment factor is selected.
Aquatic organisms
Table 1a. NaDCC and CYA - selected data
freshwater species
Taxonomic groups and species |
Acute L(E)C50 (mg/l) NaDCC |
Acute L(E)C50 (mg/l) CYA |
Algae |
|
|
Selenastrum
capricornutum |
No data available |
655 mg/L of CYA |
Crustacea |
|
|
Daphnia magna |
0.196 µg/L |
> 1000 mg/L of CYA |
Pisces |
|
|
Salmo gairdneri |
0.22 |
756 mg/L of CYA |
Acute
toxicity endpoints for the active substance NaDCC are available only for
crustaceans and fish. Thus no PNEC could be derived. A complete set of
ecotoxicity data is available for the transformation product cyanuric acid (CYA).
Table 1b PNEC derivation for surface water
Starting point |
Assessment
factor |
LC50 mg
a.s./L |
PNEC |
NaDCC |
|
|
|
Acute toxicity to
Daphnia |
- |
- |
Insufficient data to
determine* |
TCCA |
|
|
|
Acute toxicity to Daphnia magna |
Acute: 100 Chronic: 1000 |
0.21 |
Acute: 2.1 µg/L Chronic: 0.21 µg/L |
CYA |
|
|
|
Acute toxicity to algae |
Acute: 100 Chronic: 1000 |
655 |
Acute: 6.6 mg/L Chronic: 0.66 mg/L |
Active chlorine |
|
|
|
Adhoc MTR |
|
|
0.3 µg/L |
*
ecotoxicity data on algae are missing. Additionally in the literature
contradicting data on the toxicity of NaDCC to Daphnia are available.
PNECstp
Data
concerning the toxicity of CYA to active sludge are available. No data are
available concerning the toxicity of NaDCC
Table 2 PNEC derivation for STP
Starting point |
Assessment
factor |
EC50 mg
a.s./L |
PNEC |
NaDCC |
|
|
|
Active sludge |
|
|
Insufficient data to
derive PNEC |
TCCA |
|
|
|
Active sludge |
100 |
59 |
0.59 mg a.s./L |
CYA |
|
|
|
Active sludge |
100 |
3402 |
34 mg/L |
Soil organisms
Studies in which the test organisms were exposed to NaDCC and TCCA via
soil are not available. One acute toxicity earthworm test result is available
for cyanuric acid with a NOEC of 756 mg/kg wwt.
PNEC soil:
Insufficient
data is available to derive a PNEC soil for NaDCC and TCCA. One acute toxicity
study with earthworms is available for CYA with a NOEC of 756 mg/kg ww, which
is insufficient for a reliable PNECsoil. Therefore for transformation product
CYA a PNECsoil is determined on basis of equilibrium partitioning.
Table 3 PNEC derivation for the soil
Starting point |
Assessment
factor |
Ksoil-water |
PNEC |
NaDCC |
|
|
|
Not determined |
- |
No Koc available |
Not calculated |
CYA |
|
|
|
PNECaquatic
= 0.66 mg / L |
1 |
4.7 |
1.8 mg/kg ww 2.0 mg/kg dw |
Air
No methodology is available to derive a PNEC for air. The air compartment
is assessed qualitatively on basis of intrinsic properties.
Birds and mammals
Table 4 PNEC derivation for birds and mammals
Starting point |
Assessment
factor |
Lowest
test LD50 |
PNEC |
NaDCC |
|
|
|
Dietary LD50 bird |
3000 |
1766 mg/kg bw |
0.59 mg/kg bw |
TCCA |
|
|
|
Dietary LD50 bird |
3000 |
1630 mg/kg bw |
0.54 mg/kg bw |
CYA |
|
|
|
Chronic NOAEL rat |
30 |
190 mg/kg bw/day, |
6.3 mg a.s./kg bw |
Results of
the ESD calculations are presented in the tables below. Input data for the
active susbstance and/or cyanuric acid are derived from the PGB
No. |
Area of use envisaged |
Dosage a.s. |
Dosage Cyanuric acid |
|
PT2 |
|
|
1. |
Accommodations for people |
|
0.3 g/L |
2. |
Areas/surfaces in hospitals and health care
facilities including medical instruments, cleaning equipment, toilets,
textiles etc. |
|
5.5 g/L |
3. |
Therapeutic baths, private pools (not part
of hotels), camping sites, recreation centres or boarding schools |
|
|
4. |
Water in casks, buckets, vases for flowers |
|
0.03 g/L |
|
PT3 |
|
|
5. |
Accommodations for animals and annexes
including cleaning equipment |
|
1.4 g/L |
6. |
Vehicles for animal transport a. disinfection at
farms b. centralised
disinfection |
|
1.4 g/L |
|
PT4 |
|
|
7. |
Milking equipment on farms, including
pipelines, tanks, machinery etc. |
|
0.24 g/L |
8a. |
Locations where food and drinks are prepared
or stored – surfaces, instruments, systems, cleaning equipment |
|
0.72 g/L |
8b |
Beverage industry |
|
0.72 g/L |
1.
Disinfection of surfaces in industrial, public areas PT2:
Calculation
for cyanuric acid
Table 1. Disinfection of surfaces in
industrial, public areas PT2: |
|
|
|||
-
spraying with trigger spray |
|
|
|
|
|
- wiping with mop and bucket (disinfection of
floors) |
|
|
|
||
- wiping with cloth and bucket (disinfection
of other surfaces than floors) |
|
|
|||
|
|
|
|
|
|
Variable/parameter |
Unit |
Symbol |
S/D/O/P |
Value |
Remark |
Fraction released to waste water for “sanitary
purpose” |
[--] |
Fsan,water |
D |
0.55 |
ESD,
table 2.13 |
Fraction released to waste water for “brushes” |
[--] |
Fobj,water |
D |
0.95 |
ESD,
Table 2.13 |
Concentration at which the active substance is
used |
[kg/L] |
Csan/
Cobj |
S |
0.0003 |
|
Amount of water with active substance for
“sanitary purpose” |
[L] |
Qwater_san |
S |
50 |
|
Amount of water with active substance for
“brushes” |
[L] |
Qwater_obj |
S |
50 |
Idem |
Output: |
|||||
Elocalwater san= Emission rate to waste water,
sanitary purpose [kg/d] = disinfection of floors |
|||||
Elocalwater obf= Emission rate to waste water,
brushes [kg/d] = disinfection of surfaces other than floors |
|||||
Elocalwater san+obj= Emission rate to waste
water, sanitary purpose + brushes [kg/d] = spray application |
|||||
Calculation: |
|
|
|||
Elocalwater san = Qwater_san * Csan *
Fsan,water |
0.008 |
kg/d |
|||
Elocalwater obj = Qwater_obj * Cobj * Fobj,water |
0.014 |
kg/d |
|||
|
|
|
|||
Elocalwater san+obj = (Qwater_san * Csan *
Fsan,water) + (Qwater_obj * |
0.023 |
kg/d |
|||
Cobj
* Fobj,water) |
|
|
Table 2.1 Disinfection of surfaces in health
care areas – PT2 |
|
|
|
||||
-
spraying with trigger spray |
|
|
|
|
|
||
- wiping with mop and bucket (disinfection of
floors) |
|
|
|
|
|||
- wiping with cloth and bucket (disinfection
of other surfaces than floors) |
|
|
|||||
|
|
|
|
CYA |
|
||
Variable/parameter |
Unit |
Symbol |
S/D/O/P |
Value |
Remark |
||
Fraction released to waste water for “sanitary
purpose” |
[--] |
Fsan,water |
D |
0.55 |
ESD,
table 2.13 |
||
Fraction released to waste water for “brushes” |
[--] |
Fobj,water |
D |
0.95 |
ESD,
Table 2.13 |
||
Concentration at which the active substance is
used |
[kg/L] |
Csan/
Cobj |
S |
0.0055 |
|
||
Amount of water with active substance for
“sanitary purpose” |
[L] |
Qwater_san |
D |
25 |
|
||
Amount of water with active substance for
“brushes” |
[L] |
Qwater_obj |
D |
25 |
|
||
Output: |
|||||||
Elocalwater san= Emission rate to waste water,
sanitary purpose [kg/d] = disinfection of floors |
|||||||
Elocalwater obf= Emission rate to waste water,
brushes [kg/d] = disinfection of surfaces other than floors |
|||||||
Elocalwater san+obj= Emission rate to waste
water, sanitary purpose + brushes [kg/d] = spray application |
|||||||
Calculation: |
|
|
|||||
Elocalwater san = Qwater_san * Csan *
Fsan,water |
0.076 |
kg/d |
|||||
Elocalwater obj = Qwater_obj * Cobj * Fobj,water |
0.131 |
kg/d |
|||||
|
|
|
|||||
Elocalwater san+obj = (Qwater_san * Csan *
Fsan,water) + (Qwater_obj * |
0.206 |
kg/d |
|||||
Cobj
* Fobj,water) |
|
|
|||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
Table 2.2 Emission scenario for
calculating the release of disinfectants used in hospitals for disinfection
of scopes and other articles in washers/disinfectors |
|||||||
Variable/parameter
(unit) |
Unit |
Symbol |
S/D/O/P |
Value |
|
||
Input: |
|
|
|||||
A + B) Replacement + Once-through |
|
|
|
|
|
||
Working concentration of active ingrediënt
(g.1-1) |
g/L |
Cproc |
S |
0.3 |
Cyanuric
acid |
||
Maximum number of washers / disinfectors |
|
Nmaxmach |
D |
3 |
|
||
Volume of solution in machine (1) |
|
Vproc |
|
|
|
||
A)
Replacement |
L |
D |
100 |
|
|||
B)
Once-through |
L |
D |
10 |
|
|||
A) Replacement |
|
|
|
|
|
||
Replacement
interval (d) |
|
Tintrepl |
D |
14 |
|
||
Fraction
carry-over (-) |
|
Fcarry_over |
D |
0.015 |
|
||
Rate constant for chemical conversion (d-1) |
|
kdegdisinf |
S/D |
0 |
|
||
Output: |
|
|
|||||
Elocal3;Water =
Maximum emission rate to water (kg.d-1) |
|
|
|||||
Intermediate calculations: |
|
|
|
|
|||
A) Replacement |
|
|
|
|
|||
Concentration at day of
replacement due to carry-over (mg.1-1) |
|
|
|
|
|||
Cproccarry_over = Cproc *103 / (1 + Fcarryover)Tint-appl |
|
|
243.555 |
mg/L |
|||
Concentration at day of
replacement including conversion (mg.-1) |
|
|
|
|
|||
Cprocrepl = Cproccarry_over
* e-kdeg disinf * Tint repl |
|
|
243.555 |
mg/L |
|||
End calculations: |
|
|
|
|
|||
A) Replacement |
|
|
|
|
|||
Elocal3;Water = Nmaxmach
* Vproc * Cprocrepl * 10-6 |
|
|
0.07307 |
kg/d |
|||
B) Once-through |
|
|
|
|
|||
Elocal3;water = Nmaxmach * Vproc * Cproc *
10-6 |
|
|
0.00731 |
kg/d |
|||
1) |
For 'replacement' assumption that
replacement occurs on the same day |
|
|||||
2) |
Zero by default if no data are
supplied |
|
|||||
3) |
The subscript "3" refers
to the stage of processing in conformity with EUSES 1.0 and USES 3.0 |
|
|||||
3.
Disinfection swimming pools – PT2
Table 4.1 Discharge of swimming water by public
swimming pools into the sewage system for chronic situation
Variable/parameter (unit) |
|
Symbol |
Active chlorine |
CYA |
S/D/O/P |
Input: |
|
|
|
|
|
Water surface (m ) |
|
AREAswimw |
440 |
440 |
D |
Average depth of water (m) |
|
DEPTHswimw |
1.8 |
1.8 |
D |
Number of visitors per day (-) |
|
Nvisit |
400 |
400 |
D |
Concentration
in swimming water |
(kg/m3) |
Cproc_chronic |
0.005 |
0.1 |
S |
Concentration of the active substance in swimming water after shock
disinfection |
(kg/m3) |
Cproc_acute |
0.1 |
0.1 |
|
Water replaced per visitor (m ) |
|
Vrepl |
0.05 |
0.05 |
D |
Output: |
|
|
|
|
|
Elocalwater_acute = Emission rate to waste
water after shock disinfection [kg/d] |
|||||
Elocalwater_chronic = Emission rate to waster
water, daily release [kg/d] |
|
||||
|
|
|
|
|
|
Calculation: |
|
|
|
|
|
Elocalwater_acute = (AREAswim * DEPTHswim *
Cproc) / 1 = 792 kg/d |
79.2 |
79.2 |
kg/d |
||
Elocalwater_chronic = (Nvisit * Vrepl * Cproc)
/ 1 |
|
0.1 |
2 |
kg/d |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4.2 Discharge of swimming water by public and
private swimming pools into the surface water for the acute situation |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
Variable/parameter (unit) |
|
Symbol |
Active
chlorine |
CYA |
S/D/O/P |
Input: |
|
|
|
|
|
Type of swimming pool
(public/private) |
POOLTYPE |
|
|
P |
|
Dilution factor for (-): |
|
DILUTION |
|
|
D |
public
swimming pools |
|
|
4 |
4 |
|
private
swimming pools |
|
|
2 |
2 |
|
Depth of ditch (m) |
|
DEPTHditch ° |
0.3 |
0.3 |
D |
Concentration
in swimming water |
(kg.m3) |
Cproc |
0.005 |
0.1 |
S |
Parameters requiredfor distribution modules . |
|
|
|
||
Fraction drift related to location
and way of |
Fdrift |
1 |
1 |
Oc |
|
application
(-) |
|
|
|
|
|
c |
|
|
|
|
|
Application interval (d) |
|
Tint |
1 |
1 |
Oc |
Number of applications in one year
(-) |
Nappl |
1 |
1 |
O' |
|
|
|
|
|
|
|
Output: |
|
|
|
|
|
Public
pools |
|
|
|
|
|
Cwaterpest-1appl
= Cproc / dilution |
|
|
0.00125 |
0.025 |
g/L |
Private
pools |
|
|
|
|
|
Cwaterpest-1appl
= Cproc / dilution |
|
|
0.0025 |
0.05 |
g/L |
1) Already defined in distribution
model for pesticides (symbol DEPTHditch) |
|||||
2) use symbols with subscripts
(Fdrift, Tinterval and Nappl respectively) |
|
4. Water
in casks, buckets, vases for flowers
Table 4.1 Discharge of treated water for flowers
from flower auctions |
|
||
Variable/parameter |
|
Cyanuric acid |
Unit |
Product application dose |
C |
0.03 |
g/L |
Step 1. amount of water used for cut
flower treatment |
|
||
Number of cut
flowers sold in |
A |
1.85E+10 |
stems per year in |
number of stems
per liter |
B |
50 |
|
Amount of water
used in |
|
370200 |
m3 of water per
year |
Step 2. amount of product used for cut
flowers treatment |
|
||
Formula: A/B x C = |
D |
11106 |
kg per year in |
Market share actisan |
E |
1 |
[-] |
Actisan (D*E) |
F |
11106 |
kg per year in |
Step 3. amount of product emitted from NL
auctions |
|
||
NL fraction of
European market for cutflowers |
G |
0.88 |
[-] |
Used in cut
flowers industry in the |
H |
9773.28 |
kg per year in |
Flowers
transported dry: water released by auctions |
I |
0.58 |
[-] |
Amount released
from auctions (G*H) |
J |
5668.50 |
kg per year in |
|
|
|
|
Number of auctions |
|
6 |
Flora holland locations |
Number of emission days |
|
200 |
days |
Amount emited per
auction (J/days/8) |
|
4.7 |
kg per day |
5. Accommodations
for animals and annexes
Emissions
to soil and leaching to ground water after removal to manure storage after
disinfection of animal accommodations.
Input
values:
Table 5.1: Number of
disinfection events and biocide application intervals; the
subscript cat-subcat presents the animal (sub)category and for poultry the type
of housing.
Cat-subcat |
Category |
Subcategory |
Housing |
Number of disinfection events in one year |
Biocide application intervall Tbioc-int |
Reference |
Napp-bioc |
[ d ] |
|||||
[ - ] |
|
|||||
1 |
Cattle |
Dairy cow |
|
1 |
365 |
KTBL |
2 |
|
Beef cattle |
|
1 |
365 |
KTBL 2006 |
3 |
|
Veal calf |
|
4 |
91 |
KTBL 2006 |
4/5 |
Pigs |
Sows |
|
5 |
73 |
KTBL 2006 |
6 |
|
Fattening pig |
|
3 |
122 |
KTBL 2006 |
7 |
Poultry |
Laying hen |
Battery
aeration |
1 |
365 |
KTBL 2006 |
8 |
|
|
Deep pit, |
1 |
365 |
KTBL 2006 |
high-rise |
||||||
9 |
|
|
Compact |
1 |
365 |
KTBL 2006 |
10 |
|
|
Battery |
1 |
365 |
KTBL 2006 |
(no treatm.) |
||||||
11 |
|
|
Free range, |
1 |
365 |
KTBL 2006 |
litter |
||||||
12 |
|
Broiler |
Free range, |
7 |
52 |
KTBL 2006 |
litter |
||||||
13 |
|
Laying hen |
Free range, |
1 |
365 |
KTBL 2006 |
grating |
||||||
14 |
|
Parent broiler |
Free range, |
1 |
365 |
deduced
from ESD for PT 18 No. 14, Table 5.6 |
≥18 weeks |
grating |
|||||
15 |
|
Parent broiler in rearing = |
Free range, |
3 |
122 |
KTBL 2006 |
Parent broilers < 18 weeks |
grating |
|||||
16 |
|
Turkeys |
Freer range, |
2 |
182 |
KTBL 2006 |
litter |
||||||
17 |
|
Ducks |
Free range, |
13 |
28 |
KTBL 2006 |
litter |
||||||
18 |
|
Geese |
Free range, |
6 |
61 |
deduced from animal cvclus
|
litter |
(= 9 weeks) |
|||||
|
(IMA 2009) |
|||||
A) |
KTBL
2006 provides detailed data on animal husbandry (especially in the online
version from which the information provided in the table is taken). For few
animal categories or housing types only data on the number of stable cleaning
events were available. In these cases, it is assumed that the number of
cleaning events equals the number of disinfection events since disinfection
of stables normally is carried out immediately after cleaning. |
Table 5.1:
Outcome of the scenario calculations ESD 18 treated manure to grassland and
arable land for cyanuric acid
Scenario |
RESULTS FOR SOIL (IN MG/KG) |
RESULTS FOR GROUNDWATER (IN MG/L) |
||||||
|
PIECsoil_grs_final |
PIECsoil_arab_final |
PIECgrs-grw-final |
PIECars-grw-final |
||||
|
manure
appl. |
slurry
appl. |
manure
appl. |
slurry
appl. |
manure
appl. |
slurry
appl. |
manure
appl. |
slurry
appl. |
1 |
0.00E+00 |
1.74E-02 |
0.00E+00 |
1.95E-03 |
0.00E+00 |
1.43E-04 |
0.00E+00 |
1.61E-05 |
2 |
0.00E+00 |
9.86E-03 |
0.00E+00 |
1.11E-03 |
0.00E+00 |
8.12E-05 |
0.00E+00 |
9.11E-06 |
3 |
0.00E+00 |
2.76E-02 |
0.00E+00 |
1.48E-02 |
0.00E+00 |
2.27E-04 |
0.00E+00 |
1.22E-04 |
4 |
0.00E+00 |
1.55E-02 |
0.00E+00 |
1.13E-02 |
0.00E+00 |
1.28E-04 |
0.00E+00 |
9.27E-05 |
5 |
0.00E+00 |
1.97E-02 |
0.00E+00 |
1.43E-02 |
0.00E+00 |
1.62E-04 |
0.00E+00 |
1.18E-04 |
6 |
0.00E+00 |
1.28E-02 |
0.00E+00 |
5.55E-03 |
0.00E+00 |
1.05E-04 |
0.00E+00 |
4.57E-05 |
7 |
0.00E+00 |
4.63E-03 |
0.00E+00 |
6.27E-04 |
0.00E+00 |
3.81E-05 |
0.00E+00 |
5.16E-06 |
8 |
0.00E+00 |
5.09E-03 |
0.00E+00 |
7.00E-04 |
0.00E+00 |
4.19E-05 |
0.00E+00 |
5.76E-06 |
9 |
5.09E-03 |
0.00E+00 |
7.00E-04 |
0.00E+00 |
4.19E-05 |
0.00E+00 |
5.76E-06 |
0.00E+00 |
10 |
0.00E+00 |
5.09E-03 |
0.00E+00 |
7.00E-04 |
0.00E+00 |
4.19E-05 |
0.00E+00 |
5.76E-06 |
11 |
1.20E-02 |
0.00E+00 |
1.75E-03 |
0.00E+00 |
9.90E-05 |
0.00E+00 |
1.44E-05 |
0.00E+00 |
12 |
7.90E-03 |
0.00E+00 |
6.22E-03 |
0.00E+00 |
6.50E-05 |
0.00E+00 |
5.12E-05 |
0.00E+00 |
13 |
0.00E+00 |
8.96E-03 |
0.00E+00 |
1.30E-03 |
0.00E+00 |
7.37E-05 |
0.00E+00 |
1.07E-05 |
14 |
0.00E+00 |
4.82E-03 |
0.00E+00 |
6.83E-04 |
0.00E+00 |
3.97E-05 |
0.00E+00 |
5.62E-06 |
15 |
0.00E+00 |
1.16E-02 |
0.00E+00 |
4.36E-03 |
0.00E+00 |
9.51E-05 |
0.00E+00 |
3.59E-05 |
16 |
1.33E-02 |
0.00E+00 |
3.00E-03 |
0.00E+00 |
1.10E-04 |
0.00E+00 |
2.47E-05 |
0.00E+00 |
17 |
2.26E-02 |
0.00E+00 |
1.98E-02 |
0.00E+00 |
1.86E-04 |
0.00E+00 |
1.63E-04 |
0.00E+00 |
18 |
1.00E-02 |
0.00E+00 |
6.74E-03 |
0.00E+00 |
8.26E-05 |
0.00E+00 |
5.54E-05 |
0.00E+00 |
6 Vehicles for animal transport
6.a emission
to soil at farms from disinfection of vehicles used for animal transport
Table 6.2:
Emission scenario for the disinfection at farms of vehicles used for animal
transport with direct release of chlorine to soil after treatment
Parameters |
Nomenclature |
Active
chlorine |
CYA |
Unit |
||
Inputs |
||||||
Area of 1 truck (mammal transports) |
AREAmam |
140 |
140 |
[m2] |
||
Content of active ingredient in formulation (dilution) |
Fbioc |
1.6 |
1.4 |
[g.l-1] |
||
Amount of (diluted) product prescribed to be used per m2 |
Vdili2,i3 |
0.4 |
0.4 |
[l.m-2] |
||
Dilution factor (for preparation of the working solution from the
formulation (product)) |
Fdil A) |
1 |
1 |
[
- ] |
||
Fraction released to air |
Fair i2,i3,i4 B) |
0.1 |
0.1 |
[ - ] |
||
Fraction released to waste water |
Fsoil i2,i3,i4 |
(1-Fair) |
(1-Fair) |
[ - ] |
||
Number of disinfectant applications in one year |
Napp-bioc |
365 |
365 |
[
- ] |
||
Standard concentration in air at |
Cstdair C) |
2.78E-04 |
2.78E-04 |
[mg.m-³] |
||
Outputs |
||||||
Intermediate calculations |
||||||
Amount of active ingredient to be used for one application |
Qai-prescri2,i3 |
|
|
[ kg ] |
||
Mammal transports: |
||||||
Qai-prescri2,i3 = 10-3
• Fbioc • Vprodi2,i3 • Fdil • AREAmam |
0.0896 |
0.0784 |
kg/d |
|||
Calculation |
||||||
Air exposure: |
|
|
|
|
|
|
Edirectair i2,i3,i4 = Qai-air i2,i3,i4 = Fair i2,i3,i4 • Qai-prescri2,i3 |
0.00896 |
0.00784 |
kg/d |
|||
Cdirectair i2,i3,i4 =Edirectair i2,i3,i4·•
Cstdair•Napp-bioc /(365•10^6) |
2.49E-13 |
2.18E-13 |
mg/m3 |
|||
|
|
|
|
|
|
|
Soil |
|
|||||
Qsoil i2,i3,i4 = Fsoil i2,i3,i4 • Qai-prescri2,i3,i4 |
|
|
8.06E-02 |
7.06E-02 |
kg/d |
|
Soil surface area treated truck |
|
30 |
30 |
m2 |
||
Volume |
|
3 |
3 |
m3 |
||
RHO soil |
|
1700 |
1700 |
kg/m3 |
||
Concentration in soil |
|
15.8 |
13.8 |
mg/kg soil |
b. Central
disinfection:
Table 6.1:
Emission scenario for the disinfection of vehicles used for animal transport
Input for Cyanuric acid
Parameters |
Nomenclature |
CYA |
|
Unit |
|
Inputs |
|||||
Area of trucks (mammal transports) |
AREAmam |
4546 |
D |
[m2] |
|
Area of trucks (poultry transports) |
AREApoul |
1120 |
D |
[m2] |
|
Area of containers (poultry transports) |
AREAcont |
3355 |
D |
[m2] |
|
Content of active ingredient in formulation (dilution) |
Fbioc |
1.4 |
|
[g.l-1] |
|
Amount of (diluted) product prescribed to be used per m2 |
Vdili2,i3 |
0.4 |
|
[l.m-2] |
|
Dilution factor (for preparation of the working solution from the
formulation (product)) |
Fdil A) |
1 |
|
[
- ] |
|
Fraction released to air |
Fair i2,i3,i4 B) |
0.1 |
|
[ - ] |
|
Fraction released to waste water |
Fstp i2,i3,i4 |
(1-Fair) |
|
[ - ] |
|
Number of disinfectant applications in one year |
Napp-bioc |
365 |
|
[
- ] |
|
Standard concentration in air at |
Cstdair C) |
2.78E-04 |
|
[mg.m-³] |
|
Outputs |
|||||
Air Exposure |
|||||
Emission to air from one application |
Qai-airi2,i3,i4 =
Edirectair i2,i3,i4 |
|
|
[ kg ] |
|
Annual average concentration in air at |
Cdirectair i2,i3,i4 |
|
|
[mg.m-3] |
|
STP |
|||||
Emission from one application to a standard STP or an on-site waste
water treatment plant |
Qai-stpi2,i3,i4 =
Elocalwaste water i2,i3,i4 |
|
|
[kg.d-1] |
|
Intermediate calculations |
|||||
Amount of active ingredient to be used for one application |
Qai-prescri2,i3 |
|
|
[ kg ] |
|
Mammal transports: |
|||||
Qai-prescri2,i3 = 10-3
• Fbioc • Vprodi2,i3 • Fdil • AREAmam |
2.90944 |
|
kg/d |
||
Poultry transports: |
|||||
Qai-prescri2,i3 = 10-3
• Fbioc • Vprodi2,i3 • Fdil • (AREApoul +
AREAcont) |
|
|
2.864 |
|
kg/d |
Calculation |
|||||
Air exposure: |
|||||
Edirectair i2,i3,i4 =
Qai-air i2,i3,i4 = Fair
i2,i3,i4 • Qai-prescri2,i3 |
0.290944 |
|
kg/d |
||
Cdirectair i2,i3,i4 =Edirectair i2,i3,i4·• Cstdair •
Napp-bioc / ( 365 • 10^6) |
|
|
8.09E-12 |
|
mg/m3 |
STP |
|
||||
Qai-stp i2,i3,i4 = Fstp i2,i3,i4 • Qai-prescri2,i3,i4
|
|
|
2.62 |
|
kg/d |
A) For
example: If the formulation is diluted 1/10 (= 1:10), the dilution factor is
10-1. If the formulation (product) is also used as working
solution, the dilution factor is 1. |
|||||
B) Default value for Fair derived from the A-tables of the
TGD (IC = 1: AGRICULTURAL INDUSTRY; Table A3.1 – Default emission factor to
air). |
|||||
C) According to Technical Guidance Document on Risk Assessment
(TGD) in support of … Directive 98/8/EC, Part II (EC 2003a). |
7. Milking
equipment on farms, including pipelines, tanks, machinery etc.
Table 7.1: Scenario description, parameters/variables and default
for the disinfection of milking parlour systems (adopted from Baumann, 2000)
emission of cyanuric acid
Parameters |
Nomenclature |
Value |
Unit |
Origin |
Input |
||||
Concentration of active
ingredient |
Cform |
0.24 |
[g.l-1] |
S |
Amount
of disinfectant used for cleaning of the milking installation |
Vforminst |
130 |
[l.d-1] |
D |
(= 2 • 65) |
||||
Amount
of disinfectant used for cleaning of the milk storage tank |
Vformtank |
45 |
[l.d-1] |
D |
Fraction of substance
disintegrated during or after application (before release to the sewer
system) |
Fdis |
0 |
[ - ] |
D |
Fraction
of the emission to waste water |
Fwater |
1 |
[ - ] |
D |
Output |
||||
Quantity
of active ingredient used |
Qa.i. |
42 |
[g.d-1] |
O |
Local
emission to waste water |
Elocal3,water |
0.042 |
[kg.d-1] |
O |
Model calculation |
|
|
||
Qa.i. = Cform.
• (Vforminst
+ Vformtank) |
|
|
|
|
Elocalwater =
Qa.i. • (1 - Fdis) • Fwater / 1000 |
|
|
|
|
8a. Locations where food and drinks are
prepared or stored – surfaces, instruments, cleaning equipment
Table
8a: Emission scenario for calculating the releases of disinfectants used in
large scale catering kitchens, canteens, slaughterhouses and butcheries (IHO 2006) calculated for cyanuric acid
Variable/parameter |
Nomenclature |
Slaughter
houses |
Kitchens
/ canteens |
Unit |
Total |
Application rate of the product plus
dilution water |
Qappl |
0.04 |
0.04 |
[l/m2] |
|
Concentration of active substance in the use
solution |
Cform |
0.00072 |
0.00072 |
[kg/l] |
|
Surface of the treated area |
S |
10000 |
2000 |
[m2] |
|
Number of applications per day |
Nappl |
3 |
1 |
[d-1] |
|
Fraction of disinfectant emitted to the waste
water |
Fwater |
1 |
1 |
[--] |
|
without
pre-treatment |
|
1 |
1 |
|
|
with
pre-treatment |
|
0.1 |
0.1 |
|
|
Fraction of substance disintegrated during or
after application (before release to the sewer system) |
[
- ] |
0 |
0 |
Fdis |
|
Fraction of substance eliminated due to
on-site pre-treatment of waste water |
[
- ] |
0 |
0 |
Felim |
|
|
|
|
|
|
|
Output
: |
|
|
|
|
|
Elocalwater = Local emission to waste water
(without pre-treatment) |
|
|
|
|
|
Elocalwater_pre-treat = Local emission to
waste water (with pre-treatment) |
|
|
|
|
|
|
|
|
|
|
|
Calculation: |
|
|
|
|
Sum |
Elocalwater = Qappl *Cprod * S * Nappl *
Fwater * (1 - Fdis) • (1 – Felim) |
[kg/d] |
0.864 |
0.0576 |
[kg/d] |
0.9216 |
Elocalwater_pre-treat = Qappl * Cprod * S *
Nappl * Fwater * (1 - Fdis) • (1 – Felim) |
[kg/d] |
0.0864 |
0.00576 |
[kg/d] |
0.09216 |
8b Beverage industry
Table 8b: Emission scenario for calculating the releases of
disinfectants used in entire plants (e.g. breweries, dairies, beverage
processing plants) (IHO 2006) Calculated for chlorine,
sodiumdichlorocyanurate and cyanurate acid
Parameters |
Nomenclature |
Value |
Unit |
Origin |
|
Input |
|
|
|
|
|
Amount of biocidal active substance used per
year in the local plant |
Qa.i. |
228* |
[kg.yr-1] |
P |
|
(Table
6) |
|
||||
Number of emission days per year |
Temission |
231 |
[d.yr-1] |
D |
|
Amount of biocidal active substance used per
day in the local plant |
Qa.i. |
0.987 |
[kg.d-1] |
|
|
|
|
|
|
|
|
Fraction
released to wastewater |
Fwater |
1 |
[
- ] |
D |
|
Fraction of substance eliminated due to
on-site pre-treatment of the plant waste water |
Felim |
0 |
[
- ] |
D |
|
Fraction of substance disintegrated during or
after application (before release to the sewer system) |
Fdis |
0 |
[
- ] |
D |
|
Capacity
of the STP |
|
|
[m³.d-1] |
D |
|
On-site
STP |
CAPSTP_on-site |
52000000 |
L/a |
|
|
|
CAPSTP_on-site |
113 |
m3/d |
|
|
Off-site STP (standard STP according to the
TGD) |
CAPSTP_off-site |
2000 |
[m3/d] |
|
|
Dilution factor in surface water (standard
default according to the TGD) on-site |
DILon site |
10.0 |
[ - ] |
S |
|
Dilution factor in surface water (standard
default according to the TGD) off-site |
Dil off site |
10 |
|
|
|
Output |
|
|
|
||
Influent concentration of active substance in
the STP |
Cinfluent |
|
[mg.l-1] |
O |
|
Calculation |
|
|
|
||
On-site
treatment of waste water and direct release to surface water: |
|
||||
Cinfluent (PECsw) =
(Qa.i. / Temission) • 1,000 • (1 - Fdis) • (1 – Felim) • Fwater /
CAPSTP_on-site * DIL |
|
||||
Off-site
treatment of waste water: |
|
||||
Cinfluent =
(Qa.i. / Temission) • 1,000 • (1 - Fdis) • (1 – Felim) • Fwater / CAPSTP_off-site |
|
||||
|
|
Chlorine |
Sodium
dichloroisocyanurate |
Cyanuric
acid |
|
PECstp
on site |
mg/L |
8.76E+00 |
1.38E+01 |
8.07E+00 |
|
PECstp
off site |
mg/L |
4.94E-01 |
7.76E-01 |
4.55E-01 |
|
PECsw
on site |
mg/L |
8.76E-01 |
1.38E+00 |
8.07E-01 |
|
PECsw
off site |
mg/L |
4.94E-02 |
7.76E-02 |
4.55E-02 |
|
* It is assumed that all chlorine in the plant is applied as sodiumdichloroisocyanurate tonnage